您好！欢迎访问乐鸿捕鱼苹果官方版下载 网站！
返回首页 | 在线留言 | 联系我们
全国服务咨询热线:

15921799099

热门关键词：ORAcollectDNA唾液采集器,D-荧光素钾盐,微渗泵,巢料片,线性聚乙烯亚胺,2型胶原酶,,模拟胃肠液,apjtrading
当前位置：首页 > 技术文章 > cellbank产品目录

cellbank产品目录

更新时间：2019-09-10      点击次数：13844

 

RIKEN是日本大的综合性研究机构，以各种科学学科的高质量研究而闻名。RIKEN成立于1917年，是东京的私人研究基金会，其规模和范围迅速发展，如今已遍布日本各地的研究中心和研究机构网络。

 

cellbank产品目录如下：

货号品名特征
RCB0002ARM193Anti-recA protein mAb (IgG2b)
RCB0005BALB/3T3 clone A31Contact-inhibited semi-normal cell line
RCB0007HeLaJust like ATCC CCL 2, HeLa
RCB0008V79Chinese hamster lung fibroblast
RCB0009PC-12Pheochromocytoma, differentiate by NGF stimulation
RCB0012M227Infected with ts mutant of Kirsten sarcoma virus
RCB0016CCRF-HSB-2T cell leukemia
RCB0026PAb1400Anti-SV40 large T antigen mAb (IgG)
RCB0027K562Chronic myelogenous leukemia, sensitive to NK cell. Differentiate to erythroid cells .
RCB0032FM3A FT-101Temperature-sensitive, forms multiple nuclei
RCB0033FM3A tscl.T85 TsaiTemperature-sensitive at chromosome condensation
RCB0034FM3A ts T244Temperature-sensitive at DNA polymerase
RCB0035WEHI-3Secrete growth factors for hematpoietic stem cells
RCB0036C127Host for bovine papiloma virus
RCB0041HL60Differentiate to granulocytes and monocytes
RCB0043NRKContact-inhibited semi-normal, original of NRK49F
RCB0056NIH3T3/14-1Spontaneous transformant of NIH3T3
RCB0057NIH3T3/13C7SV40 large T (tsA58)-pBR322 transformed NIH3T3.
RCB0063JTC-15Subclone of AH-66, lost transplantability in rats.
RCB0065JTC-27Ascites hepatoma.
RCB0067MCapable to form collagen network
RCB0069RLC-16Epithelial cell from rat liver
RCB0070RLC-18Non tumorigenic in nude mice
RCB0072RLC-27Liver-derived cell, tumorigenic in nude mice
RCB0074JTC-19Rat lung fibroblast once said interferon-producing. Serum-& protein-free culturable.
RCB0075RCR-1Astroglia cell line
RCB0076LYM-1Sticky cell from lymph node.
RCB0083HLC-1Lung adenocarcinoma
RCB0086FM3AMammary carcinoma, grow in vitro and in vivo
RCB0095P3·NS-1/1·Ag4.1Myeloma
RCB0096Don(D-6)Pseudodiploid, two marker chromosomes
RCB0097CHLWidely used in chromosome aberration test
RCB0098A549Lung carcinoma, refer to ATCC CCL185
RCB0101L·P3Protein- & lipid-free medium growing
RCB0102IC-2Mast cell precursor, respond to IL-3. Conditioned medium.
RCB0112NRK49FContact-inhibited semi-normal cell line
RCB0115ARM321Anti-recA protein mAb (IgG1)
RCB01167501S. cerevisiae Endo.Sce I large subunit mAb (IgG2b)
RCB0120LT4TrSpontaneous transformant of LT4
RCB0135L5178YRapidly growing lymphoma
RCB0136M10Highly sensitive to X-ray irradiation
RCB0137M10^(-)Resistant to 6TG, isolated from M10
RCB0138LX830Highly sensitive to X-ray irradiation
RCB0142EhrlichEhrlich's ascite tumor
RCB0146P3-X63-Ag8.653Myeloma
RCB0153HUC-FNormal umbilical cord fibroblast, female
RCB0156305MNormal human skin fibroblast
RCB0159HS-KNormal diploid fibroblast from Japanese
RCB0162NHSF46Diploid fibroblast from normal Japanese skin.
RCB0163RGB3T3-1Original cloned line from RCB, just like BALB/3T3
RCB0164RGB3T3-5Siblings of RGB3T3-1, contact-inhibited
RCB0165REF-RGBSuitable as feeders for hybridoma cloning
RCB0169M1Differentiate to macrophage and granulocyte
RCB01717T1Contact inhibited, may transform spontaneously
RCB0174SUSM-1Transformed in vitro with carcinogen
RCB0180MDBKKidney epithelial cell, equiv. to ATCC CRL6071
RCB0183RK13Susceptible to rubella virus, equiv. to ATCC CCL37
RCB0184OLF-136Fish (medaka) fin fibroblast. Application consideration
RCB0185CAEPGold fish erythrophoroma with 4n chromosomal mode
RCB0186CAFPinna fibroblast
RCB0187OLHE-131H04C medaka hepatoma pretreated with MAM-acetate. Application consideration
RCB0188OLME-104HB32C medaka treated with MNNG. From peritoneum. Amelanotic. Cell growth is slow. Application consideration
RCB0191HeLa.S3Most famous cultured human cell line
RCB0193KMM-1Human myeloma. Lambda- chain producing.
RCB0195PAb419Anti-SV40 large T antigen mAb (IgG)
RCB0197HUC-FmNormal umbilical cord fibroblast, male
RCB0202A431High level of EGF receptor
RCB0205BU25 TK-Thymidine kinase defective HeLa
RCB0206MOLT-4T cell leukemia, the same patient as RCB1164 MOLT-3.
RCB0207MRC-5 SV1 TG1SV40-transformed, 6TG-resistant and HAT-sensitive.
RCB0208LTK-Thymidine kinase defective L cell
RCB0209SP2/0-Ag14Myeloma
RCB0210HF19Normal human lung fibroblast.
RCB0211MRC-5Normal embryonic lung fibroblast.
RCB0212CT14-G4Anti human c-myc p62 mAb (IgG1.kappa)
RCB0213NS0Myeloma. Application consideration
RCB0218MRC-5, known PDLNormal embryonic lung fibroblast with accurate PDL
RCB0222NB1RGBNormal human skin fibroblast, RCB original
RCB0224ST2Bone marrow stroma cell-derived
RCB0243Nil2C2Highly metastatic sarcoma
RCB0244Nil2C1Highly metastatic sarcoma
RCB0245Nil1C1Highly metastatic sarcoma, synthesize hematoside
RCB024710T1/2Clone 8, Contact-inhibited semi-normal
RCB02483T6Non-contact inhibited
RCB0249CKT-1Very flat and thin kidney epithelial cell
RCB0251VA-13SV40-transformed WI-38.
RCB0252W-VSV40-transformed Werner's syndrome fibroblast
RCB0256BALL-1Typical human B cell leukemia.
RCB0266CLA1RGBPseudo congenital lactic acidosis.
RCB0270KG-1-CGlioma, S-100 Protein producing. Cell growth is slow.
RCB0271HeLa S3 (SC)Suspension culturable. Useful for JIS medium inspection
RCB0273BRLES cell differentiation inhibitory activity (DIA)
RCB0275SES-MaBr-1Cabbage armyworm cell line applicable to large scale insect virus production.
RCB0276SES-MaBr-3Cabbage armyworm cell line applicable to large scale production of insect virus.
RCB0278NIAS-MB-25Show finely branched cytoplasmic processes
RCB0279NIAS-MaBr-92Susceptible to nuclear polyhedrosis virus
RCB0282NFSa Y83In vivo transplantable highly metastatic sarcoma
RCB0283C-1300Highly metastatic neuroblastoma
RCB0284Sq-1979Metastatic epithelial cell
RCB0285CHO-K1Widely used cell line, especially for biotechnol
RCB0286tk^(-)ts13Thymidine kinase-defective mutant of ts13
RCB02883Y1-B clone 1-6-2Subclone of 3Y1-B clone 1.
RCB02893Y1-B cl 1-6-K5-4-2Subclone of 3Y1-B clone 1-6.
RCB02903Y1-B clone 1Mother clone of 3Y1 series
RCB02913Y1ts-101Temperature-sensitive mutant of 3Y1 (see library).
RCB02923Y1tsC102Temperature-sensitive mutant of 3Y1, group C
RCB02933Y1ts-103Temperature-sensitive mutant of 3Y1 (see library).
RCB02943Y1ts-104Temperature-sensitive mutant of 3Y1 (see library).
RCB02953Y1ts-105Temperature-sensitive mutant of 3Y1 (see library).
RCB02963Y1tsA106Temperature-sensitive mutant of 3Y1, group A
RCB02973Y1tsB107Temperature-sensitive mutant of 3Y1, group B
RCB02983Y1ts-108Temperature-sensitive mutant of 3Y1 (see library).
RCB02993Y1ts-109Temperature-sensitive mutant of 3Y1 (see library).
RCB03013Y1ts-111Temperature-sensitive mutant of 3Y1 (see library).
RCB03023Y1tsC112Temperature-sensitive mutant of 3Y1, group C
RCB03033Y1tsC113Temperature-sensitive mutant of 3Y1, group C
RCB03043Y1ts-114Temperature-sensitive mutant of 3Y1 (see library).
RCB03053Y1ts-115Temperature-sensitive mutant of 3Y1 (see library).
RCB03063Y1tsC116Temperature-sensitive mutant of 3Y1, group C
RCB03073Y1ts-117Temperature-sensitive mutant of 3Y1 (see library).
RCB03083Y1ts-118Temperature-sensitive mutant of 3Y1 (see library).
RCB03093Y1tsC119Temperature-sensitive mutant of 3Y1, group C
RCB03103Y1ts-120Temearature-sensitive mutant of 3Y1 (see library).
RCB03113Y1tsF121Temperature-sensitive mutant of 3Y1, group F
RCB03123Y1ts-122Temperature-sensitive mutant of 3Y1 (see library).
RCB03133Y1tsD123Temperature-sensitive mutant of 3Y1, group D
RCB03143Y1tsD124Temperature-sensitive mutant of 3Y1, group D
RCB03153Y1tsG125Temperature-sensitive mutant of 3Y1, group G
RCB03163Y1tsF126Temperature-sensitive mutant of 3Y1, group F
RCB03173Y1ts-201Temperature-sensitive mutant of 3Y1 (see library).
RCB03183Y1ts-202Temperature-sensitive mutant of 3Y1 (see library).
RCB03193Y1tsH203Temperature-sensitive mutant of 3Y1, group H
RCB03203Y1tsE204Temperature-sensitive mutant of 3Y1, group E
RCB03213Y1tsC205Temperature-sensitive mutant of 3Y1, group C.
RCB03223Y1tsD206Temperature-sensitive mutant of 3Y1, group D
RCB03233Y1-SB-15Tetraploid clone of 3Y1
RCB03243Y1-SB-16Tetraploid clone of 3Y1
RCB03253Y1BU^(r-1)Thymidine kinase-defective mutant of 3Y1
RCB03263Y1BU^(r-2)Thymidine kinase-defective mutant of 3Y1
RCB03273Y1BU^(r-3)Thymidine kinase-defective mutant of 3Y1
RCB0328Ad12-3Y1-Z113Y1 transformed with adenovirus type 12
RCB0329Ad12-3Y1-Z133Y1 transformed with adenovirus type 12
RCB0330Ad12-3Y1-Z193Y1 transformed with adenovirus type 12
RCB0331Ad12-3Y1-W53Y1 transformed with adenovirus type 12
RCB0332E1A-3Y1-13Y1 transformed with adenovirus type 12 E1A gene
RCB0333E1A-3Y1-23Y1 transformed with adenovirus type 12 E1A gene.
RCB0334E1A-3Y1-33Y1 transformed with adenovirus type 12 E1A gene.
RCB0335in203-3Y1-73Y1 transformed with adenovirus in203.
RCB0336in203-3Y1-193Y1 transformed with adenovirus in203.
RCB0337in203-3Y1-233Y1 transformed with adenovirus in203.
RCB0338Ad2-3Y1-13Y1 transformed with adenovirus type 2
RCB0339Ad2-3Y1-23Y1 transformed with adenovirus type 2.
RCB0340Ad2-3Y1-33Y1 transformed with adenovirus type 2.
RCB0343SV-3Y1-C663Y1 transformed with SV40 virion.
RCB0344A640-3Y1-13Y1 transformed with SV40 tsA640
RCB0347dl-884-3Y1-KO13Y1 transformed with SV40 dl-884
RCB0350Py-3Y1-S23Y1 transformed with mouse polyoma virus
RCB0353SR-3Y1-13Y1 transformed with Rous sarcoma virus
RCB0354SR-3Y1-23Y1 transformed with Rous sarcoma virus
RCB0356HR-3Y1-13Y1 transformed with v-Ha-ras oncogene
RCB0357HR-3Y1-23Y1 transformed with v-Ha-ras oncogene
RCB0359NG-3Y1-D3033Y1 transformed with nitrosoguanidine
RCB0371NG-3Y1-T18D3Y1 transformed with nitrosoguanidine
RCB0379mos-3Y1-103Y1 transformed with v-mos oncogene
RCB0380mos-3Y1-163Y1 transformed with v-mos oncogene
RCB0381V12S-3Y1-23Y1 transformed with adenovirus type 12 12S-E1A
RCB0384V13S-3Y1-43Y1 transformed with adenovirus type 12 13S-E1A
RCB0388NCU-F1Ehlers-Danlos syndrome
RCB0389NCU-F2Morquio syndrome
RCB0390NCU-F3Wilson's disease
RCB0391NCU-F4Wilson's disease
RCB0393NCU-F6Citrullinemia
RCB0394NCU-F7Citrullinemia
RCB0395NCU-F8Wilson's disease
RCB0397NCU-F10Cockayne's syndrome
RCB0402HeLa·P3Protein- & lipid-free medium growing
RCB0403CHO-K1 (SC)CHO-K1 maintained in suspension culture.
RCB0404SES-MaBr-4Sensitive to nuclear polyhedrosis virus. Possible to grow in sea-water based low-cost medium.
RCB0405NIAS-LeSe-11Susceptible to insect viruses.
RCB0407WS2TKBWerner's syndrome
RCB0409WS1TKBWerner's syndrome, the same patient as RCB0433 WS1TKB2.
RCB0410MEN1RGBFibroblasts from multiple endocrine neoplasia
RCB0411HaP-T1Mucin producing, BHP-induced pancreatic tumor
RCB0412NIAS-PX-64Pupal ovary hemocyte.
RCB0413NIAS-MB-32Show finely branched cytoplasmic processes. Application consideration
RCB0414NIAS-MaBr-93larval hemocyte
RCB0417KU-1Bovine B cell leukemia without virus production
RCB0418KU-17Bovine leukemia virus producing. Surface Ig (+). Application consideration
RCB0420BHK-21C13-2PCulturable in suspension, cf. ECACC ( BHK-21C13-3P).
RCB0421MEN2RGBFibroblasts from multiple endocrine neoplasia
RCB0423BL312Bovine derived lymphocyte.
RCB0426SK-N-SHNeuroblastoma, a target in CTL assay
RCB0428Saos-2Osteogenic sarcoma
RCB0429SES-MaBr-5Larval fat body hemocyte.
RCB0431T24Bladder transitional-cell carcinoma
RCB0432MT-5MNNG-initiated clone of BALB/3T3 clone A31
RCB0433WS1TKB2Werner's syndrome, the same patient as RCB0409 WS1TKB.
RCB0434J774.1Macrophage-like cell
RCB0435U-937 DE-4Cloned U-937, differentiate with TNF
RCB0436HUC-F2Normal umbilical card fibroblast, female
RCB0437HUC-Fm2Normal umbilical cord fibroblast, male
RCB0438LC-1/sq-SFLung Cancer-1/squamous (RCB0455 LC-1/sq), serum-free cultured. Application consideration
RCB0439LC-1FLung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq.
RCB0440LC-2/adAdenocarcinoma, moderately differentiated. Cell growth is slow. Application consideration
RCB0441SCCKNHighly sensitive to bleomycin
RCB0443TC-YIKIntegrating HPV16, neurosecretory granules(+)
RCB0444RERF-LC-AIJapanese lung squamous carcinoma.
RCB0447ARLJ301-3Diploid rat liver epithelial cell line
RCB0448ARLJ301-3TR1Spontaneous transformant of ARLJ301-3
RCB0449Anr4EJ-ras oncogene transformed ARLJ301-3
RCB0450Anr9-1EJ-ras oncogene transformed ARLJ301-3
RCB0451Anr13-1EJ-ras oncogene transformed ARLJ301-3
RCB0452HTC/C3Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin
RCB0453SHOKContact-inhibited hamster embryonal cell line
RCB0455LC-1/sqLung Cancer-1/squamous. Parent cell line of RCB0438 LC-1/sq-SF, the same patient as RCB0439 LC-F. Cell growth is slow.
RCB0457BM-NUseful for recombinant BmNPV expression. Application consideration
RCB0466Lu-134-ASmall cell carcinoma, classic type. See Lu-134-B. Application consideration
RCB0467Lu-134-BSmall cell carcinoma, classic type. See Lu-134-A. Application consideration
RCB0468Lu-135Small cell carcinoma, variant type. Application consideration
RCB0469Lu-139Small cell carcinoma, classic type. Application consideration
RCB0470Lu-140Small cell carcimoma, classic type. Application consideration
RCB0471CYNOM-K1Cynomolgus monkey embryo skin, early passage.Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB0473DD762Mammary tumor cell line without C-type virus
RCB0474K562/MTX-2Methotrexate(MTX)-resistant K562 cell line
RCB0475ILT-MatIL-2 dependent ATL cell line. HTLV-1 pro-virus DNA(+).
RCB0476Had-1Newcastle disease virus resistant
RCB0477NB9Neuroblastoma ( Another name : CHP-212, PMID: 6871857 ) . N-myc gene amplification. Application consideration
RCB0478NB16Neuroblastoma. N-myc gene amplification.
RCB0480NB69Neuroblastoma. N-myc gene unamplified tumor. Cell growth is slow. Application consideration
RCB0481TNB1Neuroblastoma ( Another name : TGW, PMID: 2335222 ). N-myc gene amplification. Application consideration
RCB0482MC-NB-1Neuroblastoma. N-myc gene amplicon analysis. Application consideration
RCB0483LA-N-1Neuroblastoma. N-myc gene amplification.
RCB0484LA-N-2Neuroblastoma. N-myc gene amplification.
RCB0485LA-N-5Neuroblastoma. N-myc gene amplification.
RCB0486CHP-126Neuroblastoma. N-myc gene amplification. Cell growth is slow. Application consideration
RCB0487CHP-134Neuroblastoma. N-myc gene amplification. Application consideration
RCB04883Y1-B clone 1-6Standard clone of 3Y1 series. So called 3Y1
RCB0489NEC8Embryonal carcinoma, testis.
RCB0490NEC14Embryonal carcinoma, testis. Application consideration
RCB0492OTCD1TKBOTC(-), X-linked, dominant (XD)
RCB0494NEC15Embryonal carcinoma, testis. Application consideration
RCB0495KU812Chronic myelogeneous leukemia, Ph1 chromosome (+), basophil-like cells.
RCB0496KU812EChronic myelogenous leukemia , subclone of RCB0495 KU812.
RCB0497KU812FChronic myelogeneous leukemia, subclone of RCB0495 KU812.
RCB0500HGC-27Gastric cancer undifferentiated, mucin producing
RCB0503HeLa.S3(Mer^(-))Repair deficient (mer~)
RCB0504MR1-3MNNG-reistant HeLa.S3(Mer~) cells
RCB0505MR6MNNG-resistant HeLa.S3(Mer~) cells
RCB0507MR10-1MNNG-resistant HeLa.S3(Mer~) cells
RCB0508H-EMC-SSExtraskeletal myxoid chondrosarcoma
RCB0510ACL-15Metastasis to liver, lung
RCB0511RCN-9Metastasis to liver, lung
RCB0512RCN-H-4Metastasis to liver
RCB0513SKNEstradiol-17 beta responsive leiomyosarcoma
RCB0515HSKTCKrukenberg tumor cell line
RCB0520WR216APRT(-) EB transformed B cell line
RCB0521HFL-INormal embryonic lung fibroblast
RCB0522HFL-IINormal embryonic lung fibroblast
RCB0523HFL-IIINormal embryonic lung fibroblast
RCB0524HFL-AE-IHuman lung fibroblasts derived from anencephalous embryo.
RCB0525HFL-AE-IIHuman lung fibroblasts derived from anencephalous embryo.
RCB0526Jyg-MC(A)murine mammary tumor cell lines. High level MMTV producer line.
RCB0527Jyg-MC(B)Murine mammary tumor cell lines. .Higher incidence in lung metastasis.
RCB0528MtT/SEstrogen-induced tumor. Growth hormone producing. Application consideration.
RCB0529MtT/SeEstradiol-dependent pituitary tumor. Application consideration.
RCB0530MtT/SMGrowth hormone, prolactin producing. Application consideration.
RCB0531TtT/M-87Macrophage-like tumor dependent on L929 conditioned medium. Conditioned medium.
RCB0533Y1Buck-up culture of ECA85051002. Mouse steroid hormone secreting adrenal cortex cell line.
RCB0534PK15Buck-up culture of ECA86103005. Foot & mouth disease.
RCB0535RAW 264Buck-up culture of ECA8510291 . Mouse leukemic monocyte. Abelson leukemia virus induced. Application consideration
RCB0536STOTioguanine- and ouabain-resistant and HAT-sensitive fibroblasts. Suitable for ES cell feeder layer. Back up culture of ECA85061804.
RCB0537JMBuck-up culture of ECA86010201. . Human T cell line with the ability to grow HIV, the same patient as Jurkat.
RCB0538PU5-18Mouse lymphoid tumor, macrophage like. Buck-up culture of ECA85051501 .
RCB0540HAL-01Acute lymphatic leukemia
RCB0544MBT-2Murine transitional cell carcinoma induced by FANFT
RCB0545OHTAMouse embryonic carcinoma
RCB0546AT-PDH1TKBPyruvate dehydrogenase deficiency fibroblasts.
RCB0548IA-5Human large cell lung carcinoma. Taken from skin metastasis. In vivo-in vitro clonogenic assay.
RCB0549Cle-H3NIH3T3 transformant expressing human activated k-ras-2.
RCB0550Cle-H3^(neo+)pSV2neo-introduced G418-resistant Cle-H3 mutant.
RCB0554IA-LMJapanese lung large cell carcinoma
RCB0555GCIYStomach cancer (Borrmann IV). Mucin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow.
RCB0556NIAS-PX-58Pupal ovary hemocyte.
RCB0557B16 melanoma 4A5Melanin pigment producing mouse melanoma. Application consideration
RCB0558LLCHighly metastatic and drug-resistant mouse tumor. Application consideration
RCB0559K-1.flSFFV producing Friend leukemia cell line. Non-differentiating.
RCB0560F5-5.flFriend leukemia. Differentiate to erythroblastoid cells with benzidine etc.
RCB0561T-3-Cl-2-0.flFriend leukemia. Differentiate to erythroblastoid cells with 1.5% DMSO etc. A clone of TSFAT-3.fl
RCB0562TSFAT-3.flFriend leukemia. Differentiate to erythroblastoid cells.
RCB0565ATDC5Differentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived.
RCB0566CGM1EB transformed B cell line
RCB0568ULF-23Cold water fish cell line. Cultured at 25 C. Relatively large chromosomes (Mode 23).
RCB0569707.flFriend leukemia cell line. High ability to differentiate to erythroblastoid cells.
RCB0570GM86.flFriend leukemia cell line from DBA/2 mouse.
RCB0571FVTCT.flFriend leukemia cell line from BALB/c mouse. Virusnon-producing.
RCB0580SF8402Control from a nonexposed individual with breast cancer, different specimen from RCB0635
RCB0582SF8404Control from a nonexposed individual without cancer
RCB0583SF8405Control from a nonexposed individual without cancer.
RCB0584SF8406Control from a nonexposed individual without cancer.
RCB0585SF8657Control from a nonexposed individual with stomach cancer
RCB0587SF8759Atomic bomb survivor with breast cancer
RCB0588SF8760Atomic bomb survivor with breast cancer.
RCB0589SF8761Control from a nonexposed individual without cancer.
RCB0590SF8762Atomic bomb survivor with breast cancer.
RCB0591HNS1ASalamander cell line with large chromosomes. Cell growth is slow.
RCB0592HNS2Larger epithelial cells than HNS1A.
RCB0593HNS3Salamander cell line. Fibroblast-like cells.
RCB0594HNS4Salamander cell line. Epithelial-like cells.
RCB0595HNS5Salamander cell line. Fibroblast-like cells. Cell growth is slow.
RCB0596SF8758Atomic bomb survivor with breast cancer
RCB0597SF8656Control from a non-exposed individual without breast cancer but with thyroid & colon cancer.
RCB0598SF8655Atomic bomb survivor without cancer.
RCB0600SF8653Atomic bomb survivor without breast cancer but with thyroid cancer.
RCB0602SF8650Atomic bomb survivor with breast cancer
RCB0603SF8649Atomic bomb survivor with breast cancer
RCB0604SF8647Atomic bomb survivor with breast cancer.
RCB0605SF8546Control from a nonexposed individual without cancer.
RCB0608SF8543Control from a nonexposed individual with breast cancer
RCB0610SF8541Control from a nonexposed individual with uterus cancer
RCB0614SF8536Atomic bomb survivor without cancer
RCB0617SF8433Atomic bomb survivor with breast cancer
RCB0620SF8429Atomic bomb survivor with breast cancer
RCB0621SF8428Atomic bomb survivor with breast cancer, different specimen from RCB0624
RCB0624SF8425Atomic bomb survivor with breast cancer, different specimen from RCB0621.
RCB0631SF8416Atomic bomb survivor with breast cancer
RCB0633SF8414Control from a nonexposed individual with breast cancer
RCB0634SF8413Control from a nonexposed individual with chest cancer
RCB0635SF8410Control from a nonexposed individual with breast cancer, different specimen from RCB0580.
RCB0637CTLL-2Cytotoxic T-cell line. IL-2 dependent.
RCB0638TCSKeratinizing cervix squamous carcinoma, CEA(+)
RCB0641EoL-1 cellEosinophilic leukemia. Differenciate by n-butylate treatment.
RCB0644D134MoAb IgM to sea urchin sperm dynein alpha-heavy chain.
RCB0646D264MoAb IgM to sea urchin sperm dynein beta-heavy chain.
RCB0648D308MoAb IgM to sea urchin sperm dynein beta-heavy chain.
RCB0649D52MoAb IgM to sea urchin sperm dynein IC1.
RCB0650D9MoAb IgM to sea urchin sperm dynein IC2.
RCB0651D58MoAb IgG1 to sea urchin sperm dynein IC2.
RCB0654D16MoAb IgG1 to sea urchin sperm dynein IC3.
RCB0657HOKUGGlassy cell carcinoma. TA-4, CA125, neuron-specific enolase producing.
RCB0658HHUAExpressing receptor to estrogen and progesterone. Cell growth is slow.
RCB0659HOUA-IPoorly differentiated adenocarcinoma. Cell growth is slow.
RCB0660HTMMTMixed Mullerian tumor.
RCB0662HOTHCThyroid tumor. TAF, G-CSF, colloid producing.
RCB0665HFWTWilms' tumor. CA125 and TPA producing.
RCB0666HSNBN-myc propagated. Neuron specific enolase producing.Application consideration
RCB0669PCH42-63Hybridoma against differentiated PC-12 cell surface
RCB0673PCH41-43Hybridoma against differentiated PC-12 cell surface
RCB0674PCH41-44Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
RCB0676PCH42-58Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
RCB0678PCH54-37Hybridoma against differentiated PC-12 cell surface
RCB0679HDCMother of a Down's syndrome child. 46XX,t(2/q2/q)
RCB0680HKBMMHuman malignant meningioma.
RCB0684HFL-AE-IIIHuman lung fibroblasts derived from anencephalous embryo.
RCB0685SKG-II-SFLarge cell non-keratinizing squamouse carcinoma. Stage Ib. HPV type 18 integrated.
RCB0687KP-N-NSAdrenal neuroblastoma derived from brain metastasis
RCB0688QG-UJapanese cervix carcinoma.
RCB0689TCO-2Derived from a single human as TCO-1. Said CEA, CA125, TPA (+).
RCB0690HOTHC-SFSerum-free, protein-free cultured HOTHC cells
RCB0697GM2-1TKBTay-Sachs' disease
RCB0698HFSKF-IINormal human fetal skin fibroblast.
RCB0700HTMMMalignant melanoma from lympho node.
RCB0701143B/TK^(-)neo^(R)v-Ki-ras transformant TE85 cell line. HAT sensitive, neo resistant.
RCB0702WI-38The most famous normal human fibroblast. Obtained directly from L. Hayflick. Younger PDL than RCB704 at time of deposit.
RCB0704WI-38The most famous normal human fibroblast. Obtained directly from L. Hayflick.
RCB070510HAnti poly(ADP-ribose) IgG3 kappa producing.
RCB0708HF10B4Anti-human lung carcinoma mAb (IgM). Possible to culture in serum-free medium.
RCB0709HyLDH·YK-1Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG1). Possible to culture in serum-free medium.
RCB0710HyLDH·YK-2Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG2b). Possible to culture in serum-free medium
RCB0711HyGPD·YK-1-1Anti-rabbit muscle glyceraldehyde-3-phosphate dehydrogenase mAb (IgG). Serum-free culturable.
RCB0713HTUD1Large cells with large chromosomes.
RCB0715CHAUT-GSmooth muscle cell sarcoma from Chinese hamster.
RCB0721GOTO·P3Subline of GOTO. Protein-free medium adapted. Cell growth is slow.
RCB0725MS-1Small lung carcinoma. PTHrP producing.
RCB0733NLS-6-5Nalidixic acid sensitive mutant. Also sensitive toVP-16 and VM-26 Topo II inhibitors.
RCB0735OS-RC-2Renal tumor cell from a Japanese. Transplantable to nude mice.
RCB0736DJM-1Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.
RCB0738MTHC-1Rat thymoma cell line without mouse chromosome contamination. Compare to MTHC-2 and -3.
RCB0739MTHC-2Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5, 15, 17.
RCB0740MTHC-3Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5,7,15,17.
RCB0748Mm1Spontaneouly differentiated cell line derived from M1. Non-tumorigenic.
RCB0749MFH-inoHuman fibrous histiocytoma. Showing fibroblastic- and histiocytic features.
RCB0750TLR2Hepatocytes containing temperature sensitive SV40 large T antigen. P450IA1 inducible.
RCB0752TKD2Kidney epithelial cells containing temperature sensitive SV40 large T antigen. Compared to TKC2.
RCB0753OMC-1Japanese cervix squamous cell carcinoma. Once said TA-4 positive.
RCB0755OMC-3Mucinous cystadenocarcinoma. Said CA125,CA19-9 (+). Cell growth is slow.
RCB0760MT-8Rat fibrous histiocytoma. Acid phosphatase and nonspecific esterase are weakly positive.
RCB0761505-05-01Methylcholanthrene-induced fibrosarcoma. Metastatic to lung.
RCB0762MT-9Rat fibrous histiocytoma. Acid phosphatase-, non-specific esterase- & monocytic antigen-positive.
RCB0763GI-1Human glioma separated from gliosarcoma.
RCB0764Fvp^(r)B350Topoisomerase II inhibitor VP-16 resistant FM3A mutant.
RCB0768HP50-2Hydrogen peroxide resistant HL60-derived clone.
RCB0769HP100-1Hydrogen peroxide resistant HL60-derived clone. More resistant than HP50-2.
RCB0770XTYFrog (Xenopus laevis) cell line derived from subcutaneous tumor.
RCB0771XTC-YFFrog (Xenopus laevis) cell line derived from tadpole.
RCB0772A6Frog (Xenopus laevis) cell line derived from kidney.
RCB0773A8Frog (Xenopus laevis) cell line derived from liver.
RCB0774EC-GI-10Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.
RCB0775F-36PGM-CSF- or IL-3-dependent cell line. Differentiate to erythoid cells with erythropoietin.
RCB0776F-36ESubline of F-36P. Erythropoietin-dependent
RCB0777HMV-IIMelanin producing. Originated from the same site of HMV-I.
RCB0778CW-2Colon carcinoma. CEA-positive, nude mouse-transplantable.
RCB0782RC4Normal rabbit cornea cells. Usually transform spontaneously during serial culture.
RCB0783FCP-S1MSkin fibroblasts from a familial colon polyposis patient.
RCB0784FCP-S2HSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0785FCP-S3HSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0786FCP-S4HSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0787FCP-S5HSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0788FCP-S6HSkin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0789HSQ-89Japanese maxillary simus squamous carcinoma
RCB0792T88-MIL-5 dependent early B-cell line. Also grows on IL-3. The population contain non-IL-5-dependent cell
RCB0793B151K12IL-5 producing T-cell hybridoma. Culture sup is useful for T88-M cell culture.
RCB07942C6Initially insulin and glucagon producing, but not now. See RCB0795,0796,0797.
RCB07951B2C6Human embryonic pancreas-derived cell line. See RCB0794,0796,0797.
RCB07961C3D3Human embryonic pancreas-derived cell line. See RCB0794,0795,0797.
RCB07971C3IKEIHuman embryonic pancreas-derived cell line. See RCB0794,0795,0796.
RCB0803NBsusSRIsolated from a patient with hiper dopaminemia andnorepinephrinemia.
RCB0804BRF41Zebrafish fin fibroblast. Cell growth is slow.
RCB0805Ba/F3IL-3 dependent pro B cell line.　Conditioned medium. Information.
RCB0806JurkatHuman T cell line, the same patient as JM. IL-2 productivity of this line was undetermined.
RCB0808MMAcHuman melanoma, spindle-shaped. Said DOPA (+). Cell growth is slow.
RCB0819HMMMEHuman malignant mesothelioma. CA19-9, CA125, and hyaluronic acid producing. Cell growth is slow.
RCB0820HKBMLHuman brain derived lymphoma. Epstein-Barr virus positive.
RCB08448C9Producing anti-human CD36 MoAb.
RCB08673-2H3Anti-human-myeloperoxidase MoAb producing.
RCB08684-2C11Anti-human-myeloperoxidase MoAb producing.
RCB08699-1A11Anti-human-myeloperoxidase MoAb producing.
RCB087012-1B6Anti-human-myeloperoxidase MoAb producing.
RCB0871LLC-GA5-CoL150Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.
RCB0872LLC-GA5-CoL300Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.
RCB0875Chab1KMMChromosomal aberration; 46XX + (11;12)(q23.3, q15). Need confirmation.
RCB0876RGM1So called clear cells from rat stomach mucosa.
RCB0881OCUB-MSame as OCUB-1, OCUB-F.
RCB0882OCUB-FSame as OCUB-1, OCUB-M.
RCB0959HH13-1Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH17-4.
RCB0960HH17-4Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH13-1.
RCB0966HGRTBenign mature tridermal teratoma.
RCB0967HTSTHuman sacrococcygeal teratoma.
RCB0978HIRS-BMMixed mesodermal tumor consists of adenocarcinoma and rhabdomyosarcoma. Cell growth is slow.
RCB0980Sa3Squamous carcinoma cells derived from human oral cancer.
RCB0982ECC4Small-cell gastrointestinal carcinoma. High levels of creatine kinase brain isoenzyme. Cell growth is slow.
RCB0983ECC10Small cell gastrointestinal carcinoma with c-myc overexpression. Cell growth is slow.
RCB0985AeWorm cell line established by Grace. Culturable in MGM-450-10%FBS.
RCB0987C2C12Said differentiate to myotubes, but need confirmation. Backup of ECA91031101 .
RCB0988CACO-2Human colon carcinoma. Backup of ECA86010202 . Application consideration
RCB0989COLO 679Melanoma from a 47 year old female. Backup of ECA87061210 .
RCB0990CPAEBovine pulmonary artery endothelial cells producing angiotensin-converting enzyme. Bovine Viral Diarrhea Virus (BVDV) positive. Backup of ECA86111401 .
RCB0991G-361Human melanoma producing melanin up to 50 PDL. Backup of ECA88030401 .
RCB0992HOSSensitive to further transformation with both virus and chemicals. Backup of ECA87070202 .
RCB0993IEC 6Rat small intestine epithelial cells. Backup of ECA88071401 .
RCB0995MDCKCanine kidney epithelial. Sensitive to wide range of viruses. Backup of ECA84121903 .
RCB0996Mv.1.Lu(NBL-7)Aleutian mink cells. Used for focus forming assays for murine and ferine sarcoma viruses.Back up culture of ECA88050503 .
RCB0998117-13Anti-lactotetraosylceramide antibody producing. Discriminates metastatic cells from mesothelial cell
RCB0999MKN7c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.
RCB1001MKN45Poorly differentiated gastric adenocarcinoma. Producing high level of CEA.
RCB1002MKN74Moderately differentiated adenocarcinoma. Once they were hypodiploids. Cell growth is slow.
RCB1003MKN1Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.
RCB1005KP4Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.
RCB1006KP4-1Pancreatic ductal cell carcinoma. PTHrP producing.
RCB1007KP4-2Pancreatic ductal cell carcinoma. PTHrP producing.
RCB1008KP4-3Pancreatic ductal cell carcinoma. PTHrP producing.
RCB1009ECC12Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow. Application consideration
RCB1010HOEFEndometrium-derived fibroblasts.
RCB1011H-AE-IVAnencephalous embryonic fibroblast.
RCB1012T3M-5G-CSF producing thyroidal squamous carcinoma.
RCB1015T3M-1 Clone2G-CSF producing oral squamous cell carcinoma, the same patient as T3M-1 Cl-10 and CJM. Cell growth is slow.
RCB1017T3M-1 Cl-10G-CSF and IL-1 producing oral squamous cell carcinoma, the same patient as T3M-1 Clone2 and CJM.
RCB1018T3M-3Trophoblastic cell. Producing chorionic gonadotropin, estrogen, progesterone. Cell growth is slow.
RCB1020T3M-10Lung large cell carcinoma producing CSF. Cell growth is slow.
RCB1021T3M-4Pancreatic adenocarcinoma producing CEA. K-ras activated. Cell growth is slow.
RCB1022T3M-11Lung small cell carcinoma producing insulin-like growth factor II. Cell growth is slow.
RCB1024IMR-90-SVSV40 transformed human lung fibroblast.
RCB1025RTH33SV40-Adeno Vector transformed hepatocytes. Albumin secretion and urea synthesis were reported.
RCB1026GM95Glucosylceramide synthetase-deficient B16 melanoma mutant.
RCB1027MEB4Not expressing melanoma antigen. Control for GM-95 cell line.
RCB1032NOS-1Osteoid producing in vitro and in nude mice. Cell growth is slow.
RCB1033NOS-2Human osteosarcoma producing osteoid in vitro and in vivo(mouse). Cell growth is slow.
RCB1034CJMHuman cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1035CJM Cl4Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1036CJM Cl5Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1037CJM Cl6Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1038CJM Cl7Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1039CJM Cl8Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1062LMSUHuman cell line derived from lymph node metastasis of gastric cancer.
RCB1088ψCRIP-P131High-titer producer of MoMLV-derived retrovirus. A subline of ψCRIP.
RCB1089ψCRIP-MFGmGM-CSFProducer of MoMLV-derived retrovirus including mouse GM-CSF cDNA
RCB1090ψCRIP-MFGmIL-1αHigh-titer producer of MoMLV-derived retrovirus including mouse IL-1alpha cDNA.
RCB1091ψCRIP-MFGmIL-1RAHigh-titer producer of MoMLV-derived retrovirus including mouse IL-1 receptor antagonist cDNA
RCB1092ψCRIP-MFGmIL-2High-titer producer of MoMLV-derived retrovirus including mouse IL-2 cDNA
RCB1093ψCRIP-MFGmIL-3Producer of MoMLV-derived retrovirus including mouse IL-3 cDNA
RCB1094ψCRIP-MFGmIL-4Producer of MoMLV-derived retrovirus including mouse IL-4 cDNA
RCB1095ψCRIP-MFGmIL-6Producer of MoMLV-derived retrovirus including mouse IL-6 cDNA
RCB1096ψCRIP-MFGmIL-7Producer of MoMLV-derived retrovirus including mouse IL-7 cDNA
RCB1097ψCRIP-MFGmIL-10Producer of MoMLV-derived retrovirus including mouse IL-10 cDNA
RCB1098ψCRIP-MFGmIL-12p40Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p40 subunit. Refer RCB1099.
RCB1099ψCRIP-MFGmIL-12p35Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p35 subunit. Refer RCB1098.
RCB1100ψCRIP-MFGmTNF-αProducer of MoMLV-derived retrovirus including mouse TNF-alpha gene.
RCB1101ψCRIP-MFGhTNF-αProducer of MoMLV-derived retrovirus including human TNF-alpha cDNA.
RCB1102ψCRIP-MFGmLTProducer of MoMLV-derived retrovirus including mouse lymphotoxin cDNA.
RCB1103ψCRIP-MFGmG-CSFProducer of MoMLV-derived retrovirus including mouse G-CSF gene.
RCB1104ψCRIP-MFGhM-CSFProducer of MoMLV-derived retrovirus including human M-CSF gene.
RCB1105ψCRIP-MFGmIFN-γHigh-titer producer of MoMLV-derived retrovirus including mouse IFN-gamma cDNA.
RCB1106ψCRIP-MFGhMIFProducer of MoMLV-derived retrovirus including human MIF cDNA.
RCB1107ψCRIP-MFGmLIFProducer of MoMLV-derived retrovirus including mouse leukemia inhibitory factor cDNA.
RCB1108ψCRIP-MFGmKitLigandProducer of MoMLV-derived retrovirus including mouse kit ligand (SCF) cDNA.
RCB1109ψCRIP-MFGhOncost-MProducer of MoMLV-derived retrovirus including human oncostatin M cDNA.
RCB1110ψCRIP-MFGmB7Producer of MoMLV-derived retrovirus including mouse B7 (CD80) cDNA.
RCB1111ψCRIP-MFGmB7-2Producer of MoMLV-derived retrovirus including mouse B7-2 (CD86) cDNA.
RCB1112ψCRIP-MFGtrγIFNRProducer of MoMLV-derived retrovirus including the trancated form of mouse IFN-gamma cDNA.
RCB1113ψCRIP-MFGrab-IL1RAProducer of MoMLV-derived retrovirus including rabbit IL-1 receptor antagonist cDNA.
RCB1114ψCRIP-MFGratGM-CSFProducer of MoMLV-derived retrovirus including rat GM-CSF cDNA.
RCB1115ψCRIP-MFGneoProducer of MoMLV-derived retrovirus including neo gene.
RCB1116ψCRIP-MFGHSVtkProducer of MoMLV-derived retrovirus including HSV thymidine kinase cDNA.
RCB1117ψCRE-MFGts-c-srcProducer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.
RCB1118ψCRIP-MFGts-c-srcHigh-titer producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.
RCB1119ψCRE-MFGtsTHigh-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.
RCB1120ψCRIP-MFGtsTHigh-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.
RCB1124OP9Support hematpoietic stem cell and ES cell differentiation to blood cells and lymphocytes.
RCB1125TOM-2Glassy cell carcinoma from cervix. Cell growth is slow.
RCB1126MC3T3-E1Differentiate to osteoblasts. Collagen producing.
RCB1127MC3T3-G2/PA6Support hematpoietic stem cell and osteoclast differentiation. Pre-adipocyte.
RCB1129TGBC1TKBJapanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Application consideration
RCB1130TGBC2TKBJapanese gallbladder carcinoma from the same patient of TGBC1TKB. Application consideration
RCB1139HFSKF-AE-VHuman skin fibroblasts from embryo.
RCB114210H-2Anti poly(ADP-ribose) IgG3 kappa producing.
RCB1143DA-1IL-3 dependent mouse myeloid cells. MoLV induced.
RCB1144DA-3IL-3 dependent mouse myeloid cells. MoLV induced.
RCB114532DIL-3 dependent cells from Friend leukemia virus-infected mouse bone marrow.
RCB1148TGBC11TKBJapanese gastric cancer, lymph node metastated. Application consideration
RCB1151RCC10RGBKidney carcinoma from a Japanese patient. Cell growth is slow.
RCB1152SawanoNaturally raised CDDP(cisplatin)-resistant cell line.
RCB1153S2 (Drosophila)Fruit fly Oregon-R derived cell line. Highly sensitive in RNA interference compared with CHO-K1.
RCB1154KGNGranulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.
RCB1155Hepa-E1Eel hepatocyte. Application consideration
RCB1157UV-P3U1-B8Anti-thymine dimer antibody producing. Serum-free cultured hybridoma.
RCB1158B16F10/mGMMouse GM-CSF producing B16 melanoma.
RCB1164MOLT-3Human T cell leukemia, the same patient as RCB0206 MOLT-4.
RCB1165YAC-1Natural killer cell-sensitive mouse lymphoma.
RCB1166KG-1Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+
RCB1167P-815Mouse mastocytoma. Used as a target cells for cytotoxic T cell assays.
RCB1168SKW-3Human T cell leukemia (derivative of KE-37) . originally described to be established from the peripheral blood of a 61-year-old man with T cell chronic lymphocytic leukemia (CLL) in 1977; ; KE-37 was established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979
RCB1169TGBC18TKBPapillotubular adenocarcinoma of the Vater's papilla. Cell growth is slow. Application consideration
RCB1171HOUFXXX47,XX,+X-type chromosome.
RCB1174GEM-81Tumor cells derived from Gold Fish red pigment cells.
RCB1175GEM-199Tumor cells derived from Gold Fish red pigment cells.
RCB1176GEM-218Tumor cells derived from Gold Fish red pigment cells.
RCB1178HuG1-PIStomach cancer, but producing hybrid type of alkaline phosphatase. See HuG1-N.
RCB1179HuG1-NStomach cancer, but producing Nagao-type alkaline phosphatase. See HuG1-PI.
RCB1180TanoueB-lineage acute lymphoblastic leukemia.
RCB1181STA subclone of RCB1180 Tanoue.
RCB1182GR-STRCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.
RCB1184Lu-165Producing high level of anti-diuretic hormone. Application consideration
RCB1185TT1TKBRectal carcinoma from a Japanese patient. Cell growth is slow. Application consideration
RCB1186TGBC14TKBJapanese gallbladder tumor passed through a nude mouse. Application consideration
RCB1187TUHR3TKBJapanese kidney carcinoma cells. RCB original. Cell growth is slow.
RCB1188NRS-1Human rhabdomyosarcoma showing myogenic differentiation. TGFbeta inhibits it. Application consideration
RCB1189THP-1Differentates to macrophage-like cells after treatment with phorbol ester. The variant subline (RCB2128 A-THP-1). Application consideration
RCB11907-TD-1Responding to IL-6 in the bioassay.
RCB11915637Described to produce SCF, IL-1, IL-3, IL-6, G-CSF, GM-CSF, etc.
RCB1192MDA-MB-453Human breast carcinoma established from an effusion. Application consideration
RCB1193COLO-320Described to produce serotonin, epinephrine.
RCB1196TGBC24TKBJapanese gallbladder carcinoma established from metastated ascite. Application consideration
RCB1197P2UR/K-562Expressing P2U receptor acting in signal transduction pathway.
RCB1198TUHR4TKBJapanese renal carcinoma cells. Cell growth is slow.
RCB1200MMAc·SFSerum-free medium-adapted MMAc cells. For SF culture, + insulin, hEGF, hydrocortisone, bovine pituit
RCB1205Anti-PT-S1-1B7Anti-pertussis toxin subunit S-1 MoAb (IgG2a) producing.
RCB1208Anti-PT-S1-10D6Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
RCB1209Anti-PT-S1-8G4Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
RCB1212Anti-PT-S1-3F10Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
RCB1214Anti-PT-S1-4D10Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
RCB1215Anti-PT-S23-11E6Anti-pertussis toxin subunit S-2,3 MoAb (IgG1) producing.
RCB1220Anti-PT-S2-3A12Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
RCB1222Anti-PT-S2-9G8Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
RCB1223Anti-PT-S3-7E10Anti-pertussis toxin subunit S-3 MoAb (IgG1) producing.
RCB1229Anti-PT-S4-7F2Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
RCB1233Anti-PT-S4-1H2Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
RCB1238Anti-FHA(2)2E9Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
RCB1239Anti-FHA(1)1C6Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
RCB1240Anti-α(1)1C6F4MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1243Anti-α(4)11D9G5MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1244Anti-α(5)11D10B6MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1246Anti-α(7)7C9A10MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1247Anti-α(8)9F3A6MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1248Anti-α(9)12G8B11MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1250Anti-θ(1)3H10MoAb to Clostridium perfringens theta-toxin.
RCB1264tsBN2Temperature-sensitive mutant of BHK-21. Causing premature chromosome condensation.
RCB1267tsBN7Temperature-sensitive mutant of BHK-21 with mutated DAD1 gene. Causing apoptosis at 39.5 C.
RCB1268tsBN462Temperature-sensitive mutant of BHK-21. Complemented with human X-linked CCG1 gene. Application consideration
RCB1269tsBN75Temperature-senstive mutant of BHK-21. Complemented with ubiquitin-activating enzyme E1 cDNA.
RCB1270tsBN51Temperature-sensitive mutant of BHK-21 with defect in RNA polymerase III subunit.
RCB1271tsBN67Temperature-sensitive mutant of BHK-21. Stop growth after 2-day culture at 39.5 C.
RCB1272tsBN250Temperature-sensitive mutant of BHK-21. Complementation group A. Dye rapidly at 39.5 C.
RCB1273tsBN269Temperature-sensitive mutant of BHK-21 selected after MNNG treatment.
RCB1275TUHR10TKBJapanese renal carcinoma cells expressing HLA-A2402. Cell growth is slow.
RCB1278MtT/EEstrogen-induced pituitary tumor. Compared with MtT/S, MtT/SM, and MtT/Se. Application consideration.
RCB1279TtT/GFPituitary folliculo-stellate-like cells. GFAP positive and S-100 positive.
RCB1280TGBC50TKB3 cell lines from different metastases were established from the same patient. See TGBC51TKB. Application consideration
RCB1281TGBC51TKB3 cell lines from different metastases were established from the same patient. See TGBC52TKB. Application consideration
RCB1282TGBC52TKB3 cell lines from different metastases were established from the same patient. See TGBC50TKB. Application consideration
RCB1283B16 melanomaMouse melanoma producing melanin. Application consideration
RCB1284B16 melanoma/lacZMouse melanoma expressing E.coli lac Z. Strongly positive with beta-galactosidase.
RCB12853A21Anti-ribonuclease A antibody producing.
RCB1286ECPC-3Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene.
RCB1287ECPC-4Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Different shape
RCB1290OIH-1Human myeloid leukemia cell line with chromosome 18 trisomy and mutation in DCC gene. Cell growth is slow. Application consideration
RCB1292RBEHuman intrahepatic cholangiocarcinoma.Please read carefully this information before use.
RCB1293SSP-25Human intrahepatic cholangiocarcinoma. Please read carefully this information before use.
RCB1294HRC-17Hybridoma producing anti-E antigen of the human Rh blood group system
RCB1296HNT-34AML with Ph' chromosome and t(3;3)(q21;q26). Expressing EVI-1 and BCR/ABL mRNA. Application consideration
RCB1297HYT-1Human acute myeloid leukemia derived cell.
RCB1303anti-αA-crystallinAnti-chick αA-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1304anti-αB-crystallinAnti-chick αB-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1305anti-β5-crystallinAnti-chick β5-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1306anti-β6-crystallinAnti-chick β6-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1307anti-γ1-crystallinAnti-newt γ1-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1308anti-δ-crystallinAnti-chick δ-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1311C3H/HeN-embMouse(C3H/HeN Jcl) embryonic fibroblasts cultured under the 3T3 schedule.
RCB1312C57BL/6J-embMouse(C57BL/6J) embryonic fibroblasts cultured under the 3T3 schedule.
RCB1313RERF-LC-KJJapanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow.
RCB1316CTB-1Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.
RCB1317KU-SNRare peripheral neuroectodermal tumor cells. Use collagen-coated dish.
RCB1366HuH-7Said producing alpha-fetoprotein, alpha-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, etc.
RCB1367HuH-6Hepatoblastoma. Said albumin and alpha-fetoprotein producing.
RCB1369NBT-T1A subline of NBT-II. Low invasive bladder carcinoma. Relatively high cadherin expression.
RCB1370NBT-T2A subline of NBT-II. Almost non-invasive bladder carcinoma. Relatively high cadherin expression.
RCB1371NBT-L1A subline of NBT-II. Invasive bladder carcinoma. Relatively low cadherin expression.
RCB1372NBT-L2aA subline of NBT-II. Highly invasive bladder carcinoma. Relatively low cadherin expression.
RCB1373NBT-L2bA subline of NBT-II. The most invasive bladder carcinoma. Relatively low cadherin expression.
RCB13741-8CAG-loxP-neopA-loxP-LacZ(incomplete) was inserted. Control cell line for 2-2 and 2-7 cells.　Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB13752-235 copies of CAG-loxP-neopA-loxP-LacZ were tandemly inserted. Cre will delete neopA and induce LacZ.　Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB13762-7A copy of CAG-loxP-neopA-loxP-LacZ was inserted. Cre will delete neopA and induce LacZ. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB137732Dcl3Mouse IL-3 dependent cells cloned from 32D. Differentiate with G-CSF stimulation. Conditioned medium.
RCB1378MuSSA-Jackson mouse-derived histiocyte-like cells from spontaneous sarcoma.
RCB1382CF1TKBJapanese cystic fibrosis fibroblast.
RCB1383TUHR14TKBJapanese renal carcinoma cells. Cell growth is slow.
RCB1422L929TNFalpha-sensitive L929. Do not confuse with RCB0081 L929 that is insensitive to TNFalpha.
RCB1423BHK-21The parent cell line used for the temperature sensitive cell line series of BN.
RCB1425LCAM1Human lung cancer derived cell.
RCB1426PMF-ko14Japanese colon carcinoma. Family of the patient also exhibited high risk, but not so-called HNPCC.
RCB1429SN-512Japanese AML. Said i(12p)(p11) and unbalanced t(5;12). Need confirmation before use.
RCB1433TENSo called clear cell carcinoma. Said c-erb2(+), cathepsin D(+), CA125(+).
RCB1434KE-39Human cell line derived from gastric cancer
RCB1435KE-97Human cell line derived from intraperitoneal metastasis of gastric cancer
RCB1437AW-EBV-LCLB95-8 EB virus transformed leukemia cell line.
RCB1438TW-EBV-LCLB95-8 EB virus transformed (originally normal) B cell line.
RCB1440ATN-1Adult T-cell leukemia. HTLV-1 pro-virus DNA(+).
RCB1444MBHL-2Insect cell line derived from Mamestra brassicae. Cell growth is slow.
RCB1445MBHL-3Insect cell line derived from Mamestra brassicae
RCB1449C7p53 deficient mouse bone marrow derived cell. Useful for study of p53 suppressor oncogene. Cell growth is slow.
RCB1450LM8A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin).
RCB1451L929Sanford's original, brought by Katsuta at 7/5/1955. Insensitive to TNFalpha. Possible to culture in MEM medium.
RCB1456RCR-1Astroglia cell line. Possible to culture in DMEM medium. See RCB0075.
RCB1460PCM6Human myeloma cell.
RCB1464DT40Chicken B cell line transformed by avian leukosis virus. c-myc and IgM expressing.
RCB1465SHIP^(-) DT40SHIP deficient DT40 cells
RCB1466SHP1^(-) DT40SHP1 deficient DT40 cells
RCB1467IP3R^(-) DT40IP3R(type1,type2,type3) deficient DT40 cells
RCB1468Btk^(-) DT40Btk deficient DT40 cells
RCB1469PLC-γ2^(-) DT40PLC-γ2 deficient DT40 cells
RCB1470Syk^(-) DT40Syk deficient DT40 cells
RCB1471Lyn^(-) DT40Lyn deficient DT40 cells
RCB1472MCapable to form collagen network. Possible to culture in DMEM medium. See RCB0067.
RCB1473LYM-1Sticky cell from lymph node. Possible to culture in DMEM medium.
RCB1474RLC-16Epithelial cell from rat liver. Possible to culture in DMEM medium.
RCB1477CHO-RDSubline of CHO cells. Derived from CHO-K1 cell line. Serum-free medium adapted. Application consideration
RCB1483OV2944-HM-1Lymphnode-metastatic ovarian tumor. So called HM-1 cells.
RCB1484RLC-18Non tumorigenic in nude mice. Possible to culture in DMEM medium.
RCB1486JTC-19Rat lung fibroblast once said interferon-producing. Possible to culture in DMEM medium. See RCB0074 .
RCB1487MY-EBV-LCLB95-8 EB virus transformed (originally normal) B cell line.
RCB1489RLC-27Liver-derived cell, tumorigenic in nude mice. Possible to culture in DMEM medium.
RCB1495FU-RPNT-1Scarcely found primitive neuroectodermal tumor from a Japanese kidney. Application consideration
RCB1498Grap^(-) DT40Grap deficient DT40 cells
RCB1499Grb2^(-) DT40Grb2 deficient DT40 cells
RCB1500Lyn^(-)/Syk^(-) DT40Lyn and Sky deficient DT40 cells
RCB1501SHP1^(-)/SHP2^(-) DT40SHP1 and SHP2 deficient DT40 cells
RCB1502SHP2^(-) DT40SHP2 deficient DT40 cells
RCB1503Shc^(-) DT40Shc deficient DT40 cells
RCB1506clone YP1N25Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP) is possible. Cell growth is slow.
RCB1507clone YP1N27A subline of C127. PB1 RNA polymerase subunit and nucleoprotein are inducible by dexamethasone.
RCB1508clone 76Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA, PB2) is possible.
RCB1509clone 64Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA) is possible.
RCB1510BLNK^(-) DT40BLNK deficient DT40 cells
RCB1512MH7ARheumatoid fibroblast-like synoviocyte transformed with SV40 T antigen. Respond to IL-1beta.
RCB1513HOMMMelanoma cells with melanin-granules. Cell growth is slow.
RCB1514HOCEJapanese choriocarcinoma cell line. Cell growth is slow. Application consideration
RCB1517A-6(ES derived)Mouse ES ( AES0001 H-1 ) cell derived cell, useful for study of hematopoiesis.
RCB1518SS-A3-1F344 male rat fibrosarcoma cells, but with histiocytic and/or myofibroblastic characteristics.
RCB1520JHOC-5Clear cell adenocarcinoma. Said CA125, CA72-4 producing. Application consideration
RCB1521JHOS-2Ovary serous adenocarcinoma. Said CA125, CA15-3 producing. Application consideration
RCB1525HeLa.S3= RCB0191 HeLa.S3, that has been cultured in MEM(susp.). This line is cultured in MEM.
RCB1528CCP-2Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
RCB1530CCP-7Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
RCB1531CCP-8Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
RCB1534MLC-1-BBone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.
RCB1535MLC-2-4Bone marrow stroma cell line, depositing calcified matrix on the culture surface.
RCB1536MLC-6Osteoclast-like cell line derived from mouse (C3H/He). Cell growth is slow.
RCB1537MLC-7Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.
RCB153832Dcl3Subclone of 32D cell line. Differentiate to mature granulocytes by G-CSF. Conditioned medium.
RCB1539P19.CL6Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear. The efficiency of differentiation is lower compared to RCB 2318.
RCB1541HFL9t47, +del(9)(q12) chromosome, the same patient as RCB1542.
RCB1542HFSK9t47, +del(9)(q12) chromosome, the same patient as RCB1541.
RCB1543JHTKI-col-LB lymphocytes isolated from a colon adenocarcinoma.
RCB1544JHUAS-1Uterine adenosquamous carcinoma. Said CEA and CA125 producing. Cell growth is slow. Application consideration
RCB1545JHUAS-2-LB lymphocyte isolated from Japanese adenosquamous carcinoma.
RCB1546JHOS-3Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow. Application consideration
RCB1547JHUCS-1Japanese uterine carcinosarcoma. Nude mouse transplantable. Application consideration
RCB1548JHUEM-1Japanese uterine endometrioid adenocarcinoma G2. Said CA125, CEA producing. Application consideration
RCB1549YSCCCHuman cell line derived from cholangiocellular carcinoma. Cell growth is slow.
RCB1550HL-60-R2Variant of HL60. Resistant to retinoic acid and active Vit. D derivatives.
RCB1551JHUEM-2Japanese endometrioid adenocarcinoma. Application consideration
RCB1552JHUEM-3Human uterus endometrioid adenocarcinoma cell line. Application consideration
RCB1555F9Said to differentiate to parietal endoderm with retinoic acid and dibutyryl cAMP.
RCB1558JHUS-nk1Human uterus squamous cell carcinoma cell line. Application consideration
RCB1560PWS-YamaguchiPrader-Willi syndrome with obesity. del(15) was found in lymphocytes of the patient.
RCB1561RML-YoshiSevere insulin-resistance by uncleaved insulin proreceptor. G->T mutation in interconnecting region.
RCB1564ψCRIP-RxnZSubline of ψCRIP that produce virus to express LacZ possessing nuclear localization signal.
RCB1572ψCRIP-hBax-i-hCD25-CSRetrovirus producer. Produce virus to express human Bax protein.
RCB1573ψCRIP-ATR-bsrCell line producing retrovirus to express angiotensin receptor.
RCB1574ψCRIP-RxhCD82Cell line producing retrovirus to express the human CD82.
RCB1575ψCRIP-Rx-crmA-bsrCell line producing retrovirus to express the anti-apoptotic crmA.
RCB1576ψCRIP-Rx-ETBR-bsrCell line producing retrovirus to express the human endothelin receptor.
RCB1577ψCRIP-mPCNF1-bsrCell line producing retrovirus to express the mouse calcineurin.
RCB1579ψCRIP-MFG-ZCell line producing retrovirus to express lac Z.
RCB1580ψCRIP-MFG-T37Cell line producing retrovirus to express SV40 large T antigen.
RCB1581ψCRIP-MSHRCell line producing retrovirus to express human MSH receptor.
RCB1582ψCRIP-NCreCell line producing retrovirus to express Cre recombinase.
RCB1583ψCRIP-hp53-bsrCell line producing retrovirus to express human p53 and blasticidin S deaminase gene.
RCB1584ψCRIP-RxBcl-XL-i-bsrCell line producing retrovirus to express human Bcl-xL and blasticidin S deaminase gene.
RCB1585ψCRIP-RxhFAS-i-CD80Cell line producing retrovirus to express human FAS and human CD80.
RCB1587ψCRIP-RxhSecR-bsrCell line producing retrovirus to express human secretin receptor and blasticidin S deaminase gene.
RCB1588ψCRIP-hSSR-bsrCell line producing retrovirus to express human somatostatin receptor and blasticidin S deaminase gene.
RCB1589ψCRIP-RxmPCNT1-i-bsrCell line producing retrovirus to express a truncated form of mouse calcineurin and blasticidin S deaminase gene.
RCB1590ψCRIP-RxhVIPR-bsrCell line producing retrovirus to express human VIP receptor and blasticidin S deaminase gene.
RCB1591SRA 01/04alpha, beta-crystaline expressing human lense epithelial cell line. plasmid DNA: pRSV-B-T Ag.
RCB1593OS3ori- SV40 DNA transformed C3H mouse brain-derived cells. GFAP+ astrocytes and GFAP- oligodendrocytes
RCB1597KKCMouse T cell line transformed by Gross leukemia virus.
RCB1598NCKAMouse T cell line transformed by Gross leukemia virus.
RCB1600KKFMouse T cell line transformed by Gross leukemia virus.
RCB1601KKBMouse T cell line transformed by Gross leukemia virus.
RCB1604DHA3-1Mouse T cell hybridoma expressing double HA-tag alone.
RCB1605DHA3-26Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
RCB1606DMyc3-45Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2 .
RCB1607DHA9-3Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
RCB1608DHA9-13Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
RCB1609DHA9-15Mouse T cell hybridoma (DO-11.10)expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
RCB1610DMyc9-36Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
RCB1611M4Anti-chicken IgM antibody secreting. Able to stimulate DT40 cell surface antigen.
RCB1613HFL-AE-VIHuman lung fibroblasts derived from anencephalous embryo.
RCB1615HFSKF-AE-VIIHuman skin fibroblasts derived from anencephalous embryo. RCB1617 and RCB1618 are derived from the same embryo.
RCB1617HFL-AE-VIIHuman lung fibroblasts derived from anencephalous embryo. RCB1615 and RCB1618 are derived from the same embryo.
RCB1618HFLI-AE-VIIHuman liver fibroblasts derived from anencephalous embryo. RCB1615 and RCB1617 are derived from the same embryo.
RCB1620ΔDNAPK-DT40DNA PK gene deleted DT40 (chicken B cell line).
RCB1621ΔKu70-DT40Ku70 gene deleted DT40 (chicken B cell line).
RCB1622ΔRad51B-DT40Rad51B gene deleted DT40 (chicken B cell line).
RCB1623ΔRad51C-DT40Rad51C gene deleted DT40 (chicken B cell line).
RCB1624ΔRad51D-DT40Rad51D gene deleted DT40 (chicken B cell line).
RCB1625ΔXRCC2-DT40XRCC2 gene deleted DT40 (chicken B cell line).
RCB1626ΔXRCC3-DT40XRCC3 gene deleted DT40 (chicken B cell line).
RCB1627ΔRad52-DT40Rad52 gene deleted DT40 (chicken B cell line).
RCB1628ΔRad54-DT40Rad54 gene deleted DT40 (chicken B cell line).
RCB1629ΔMre11-DT40(#190)Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1630.
RCB1630ΔMre11-DT40(#194)Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1629.
RCB1631ΔRad51+hRad51-DT40Rad51 gene deleted and human Rad51 gene inserted DT40 (chicken B cell line).
RCB1632ΔKu70ΔRad54B-DT40Ku70 and Rad54B gene double-deleted DT40 (chicken B cells).
RCB1633ΔMre11ΔKu70-DT40Mre11 and Ku70 gene double-deleted DT40 (chicken B cells).
RCB1634ΔRad54ΔRad54B-DT40Rad54 and Rad54B gene double-deleted DT40 (chicken B cells).
RCB1635K-562Human CML derived cell line. Deposited directly from the institution that has established this cell.
RCB1637293Sheared human Ad5 DNA-transformed cell line. Widely used for production of manipulated adenovirus. Back up culture of ECA2737.
RCB1638Hepa 1-6Derived from BW7756 tumor in a C57L mouse. Back up culture of ECA3041.
RCB1639LoVoCEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow.
RCB1640DAUDIBurkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011.
RCB1641EL49,10-dimethyl-1,2benzanthracene induced lymphoma. Back up culture of ECA2504.
RCB16423T3 Swiss AlbinoContact inhibition. Buck up culture of ECA2854.
RCB1644BeWoIt was initiated from a malignant gestational choriocarcinoma of the fetal placenta. Need to check response to hormones before use. Back up culture of ECA2687.
RCB1645Y79Caucasian retinoblastoma. May have reverse transcriptase. Back up culture of ECA2583.
RCB1647RAJIBurkitt's lymphoma. Sensitive to LAK cells but resistant to NK cells. Back up of culture ECA2673. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles.
RCB1648Hep G2hepatocellular carcinoma. Produce alpha-fetoprotein, albumin, etc. Back up of ECA2870.Information
RCB1649ΔAtm-DT40ATM gene deleted DT40 (chicken B cells).
RCB1650ΔAtmΔKu70-DT40ATM and Ku70 gene double-deleted DT40 (chicken B cells).
RCB1651ΔAtmΔRad54+hRad54-DT40ATM and Rad54 gene double-deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
RCB1652G1MF285DHybridoma that produce anti-human G1MF (allotype of IgG1) antibody.
RCB1668293/CrmA293 cell line expressing the caspase-inhibiting CrmA gene
RCB1672ΔRad54+hRad54-DT40Rad54 gene deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
RCB1675Cbl^(-) DT40Cbl deficient DT40 cells
RCB1676JHOM-1Human ovary mucinous adenocarcinoma cell line. Application consideration
RCB1677JHUEM-7Human uterus endometrial adenocarcinoma cell line. Application consideration
RCB1678JHOS-4Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow. Application consideration
RCB1680TUHR25TKBHuman cell line derived from kidney cancer.
RCB1681GS-HepG2A subline of HepG2. Expressing abundant glutamine synthetase. Information
RCB1682JHOM-2BHuman ovary mucinous tubular adenocarcinoma cell line. Application consideration
RCB1687ΔRad54ΔKu70-DT40Rad54 and Ku70 gene double-deleted DT40 (chicken B cells).
RCB1688JHOC-7Human ovary clear cell carcinoma cell line. Application consideration
RCB1690CPN4BCell line derived from embryo of Cynops pyrrhogaster. Cell growth is slow.
RCB1691Tpit/F1Folicular dendritic cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse.
RCB1692Tpit/EImmature pituitary cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse. PMID: 24881870
RCB1695RMS-YMEmbryonal rhabdomyosarcoma cell line derived from human. Transplantable in nude mouse.
RCB1696SPB-1Serine-palmitoyl transferase deficient (temperature-sensitive) cells derived from CHO-K1 cell line.
RCB1697SPB-1/cLCB1SPB-1 derivative complemented the Serine-palmitoyl transferase deficiency.
RCB1698LY-BSerine-palmitoyl transferase (LCB1 subunit) deficient cells derived from CHO-K1 cell line.
RCB1699LY-B/cLCB1LY-B derivative complemented the Serine-palmitoyl transferase (LCB1 subunit) deficiency.
RCB1701MYHuman cell line derived from p180-BCR-ABL dependent leukemia.
RCB1702SLVLHuman cell line derived from splenic B cell lymphoma.
RCB1704BLNK^(-)/Syk^(-) DT40BLNK and Syk deficient DT40 cells
RCB1705JHCA-ovHuman colon cancer cell line derived from metastasis at ovary. Moderately differentiated adenocarcinoma. Application consideration
RCB1706JHCOLOYIHuman cell line derived from rectal cancer. Application consideration
RCB1708JHTSK-col-LHuman B cell-like cell line derived from colon adenocarcinoma tisuue.
RCB1709GE1Mouse-derived gingival epithelial cell line. Derived from SV40-Large T antigen transgenic mouse. Application consideration
RCB1716BCAP^(-) DT40BCAP deficient DT40 cells
RCB1717IP3R type1^(-)/2^(-) DT40IP3R type1 and IP3R type2 deficient DT40 cells
RCB1718IP3R type1^(-)/3^(-) DT40IP3R type1 and IP3R type3 deficient DT40 cells
RCB1719IP3R type2^(-)/3^(-) DT40IP3R type2and IP3R type3 deficient DT40
RCB1721JHUCS-3Human cervical cancer cell line. Application consideration
RCB1723JHOC-8Human ovary clear cell carcinoma cell line. Application consideration
RCB1724JHSK-recHuman rectal cancer cell line. Application consideration
RCB1728Hpr-4H2O2 resistant Chinese Hamster V79 cells
RCB1731TM-31Human cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)
RCB1734LAH3Melanophore derived cell line. Derived from Rana porosa brevipoda (albino). Cell growth is slow.
RCB1741NHOSMouse osteosarcoma cell line. Transplantable to mouse and form bone tissue in mouse.
RCB1747ΔNBS1-DT40Subline of DT40 (chicken B cell line), lacking Nbs1 expression.
RCB1749ΔDinB-DT40Subline of DT40 cell line, lacking DinB expression.
RCB1750ΔRad18-DT40Subline of DT40 cell line, lacking Rad18 expression.
RCB1752BS-SHI-4MHuman cell line derived from Bloom syndrome patient. Transformed by EBV. Can express certain antigen on the cell surface, such as cancer-specific antigen.
RCB1753KMY-JMeningioma derived cell line. Derived from rat F344.
RCB1754KMY-1Subline of KMY-J. Fibroblast-like
RCB1755KMY-2Subline of KMY-J. Epithelial-like
RCB1756KMY-3Subline of KMY-J. Polyploidy
RCB1757HS-PRat cell line derived from histiocytic sarcoma. Possessing characteristics of macrophage.
RCB1759ΔDNAPKΔKu70-DT40Subline of DT40 cell line, lacking both of DNAPK and Ku70 expression.
RCB1764ΔRev3-DT40Subline of DT40 cell line, lacking Rev3 expression.
RCB1766ΔligIV-DT40Subline of DT40 cell line, lacking ligase IV expression.
RCB1767ΔRad52ΔXRCC3-DT40Subline of DT40 cell line, lacking both of Rad52 and XRCC3 expression.
RCB1768ΔXRCC3-cond1-DT40Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
RCB1769ΔXRCC3-cond2-DT40Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
RCB1770XRCC3+/--DT40Subline of DT40 cell line, lacking XRCC3 only in one allele.
RCB1771Lu-24Human cell line derived from lung cancer. Oat cell type. Application consideration
RCB1772Lu-141Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
RCB1773Lu-143Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
RCB1785Lu-138Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
RCB1788AT805Mouse teratoma-derived cell line. Parent cell line of ATDC5.
RCB1790P19C6Embryonal carcinoma cell line derived from mouse C3H. Differentiate to nervous system.
RCB1791PCC3/A/1Mouse teratoma-derived cell line.
RCB1792SIL-6/1Subline of A-6. Dependent on SCF and IL-6 for proliferation. Differentiate to erythroid cells by IL-3.
RCB1794ΔRad18ΔXPA-DT40Subline of DT40 cell line, lacking both of Rad18 and XPA expression.
RCB1795ΔRad18ΔDinB-DT40Subline of DT40 cell line, lacking both of Rad18 and DinB expression.
RCB1797BP7(R80)Rat renal tumor derived cell line.
RCB1798BP11(R2)Rat (Wistar) cell line derived from renal (kidney) tumor.
RCB1799BP11(R100)Rat (Wistar) cell line derived from renal (kidney) tumor.
RCB1800BP13(R2)Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
RCB1801BP13(R100)Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
RCB1802BP26(R2)Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
RCB1803BP26(R80)Rat cell line derived from kidney carcinoma. After passage 80. Wistar rat.
RCB1804BP30(R2)Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
RCB1805BP30(R100)Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
RCB1806BP36B(R2)Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
RCB1807BP36B(R100)Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
RCB1809Vav3^(-) DT40Vav3 deficient DT40 cells
RCB1810PI3Kp110α^(-) DT40PI3Kp110α deficient DT40 cells
RCB1811ΔBLM-DT40Subline of DT40 cell line, lacking BLM (Bloom syndrome gene) expression.
RCB1812ΔWRN-DT40Subline of DT40 cell line, lacking WRN (Werner syndrome gene) expression.
RCB1813ΔWRNΔBLM-DT40Subline of DT40 cell line, lacking both of WRN (Werner syndrome gene) and BLM (Bloom syndrome gene) expression.
RCB1814ΔDinBΔXPA-DT40Subline of DT40 cell line, lacking both of DinB and XPA expression.
RCB1817DT40(v-myb^+)WTA subline of avian cell line, DT40, expressing v-myb exogenously.
RCB1818DT40(v-myb^+)ΔpolβA subline of avian cell line, DT40, expressing v-myb exogenously and lacking polβ gene.
RCB1819DT40(v-myb^+)ΔpolλA subline of avian cell line, DT40, expressing v-myb exogenously and lacking polλ gene.
RCB1820DT40(v-myb^+)ΔpolλβA subline of avian cell line, DT40, expressing v-myb exogenously and lacking both polβ and polλ gene.
RCB1821CHO-FLAG-hBLT1Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT1).
RCB1822CHO-HA-hBLT2Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT2).
RCB1823CHO·1F8Subline of CHO-K1 that expresses human platelet activating factor receptor.
RCB1824TRP1^(-) DT40TRP1 deficient DT40
RCB1829SC-1Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses.
RCB1830Rat-1Rat fibroblast-like cell line that can be transformed by oncogenes.
RCB1831XCCell line for titration of murine leukemia virus.
RCB1832THKSV40 transformed hamster cell line. Fibroblast-like cells.
RCB1833MinkLung epithelial cell line derived from mink. Useful for focus forming assays for murine leukemia virus.
RCB1834S+L-MinkMink (RCB1833) cells transformed by Moloney murine sarcoma virus.
RCB1835SircFibroblast-like cell line derived from rabbit.
RCB1836Grb2^(-)/Grap^(-) DT40Grb2and Grap deficient DT40 cells
RCB1837MVP1Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1838MVP25Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1839MVP47Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1840MVP49Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1841MVP51Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1845ΔUbc9+cUbc9-DT40Endogenous Ubc9 deficient DT40 cells but expressing Ubc9 exogenously
RCB1846HSC-FT cell line derived from Cynomolgus Monkey (Macaca fascicularis). Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1847ES-8040 20-2Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
RCB1848ES-8047 2-1Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
RCB1849C-8049Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
RCB1850C-8052Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
RCB1851DT40 Cre1A subline of avian cell line, DT40, expressing v-myb/pMerCreMer exogenously (see reference : BMC Biotechnol. 2001;1:7).
RCB1853MSH6-1-[ClX3.16]DT40A subline of avian cell line, DT40, lacking MSH6 (see reference : BMC Biotechnol. 2001;1:7).
RCB1854HSP-239T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1855HSP-250T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1856TX-7F (hybridoma)Hybridoma producing a monoclonal antibody against tetrodotoxin.
RCB1857DA-3 (hybridoma)Hybridoma producing a monoclonal antibody against domoic acid.
RCB1858GT-13A (hybridoma)Hybridoma producing a monoclonal antibody against gonyautoxin.
RCB1859MDBK-NSTBovine kidney-derived epithelial cell line. FBS independent for culture.
RCB1860BLNK^(-)Grb2^(-)DT40BLNK and Grb2 deficient DT40 cells
RCB1861T-23Lung fibroblastic cell line derived from Tupaia belangeri. Tupaia cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1862NIH3T3-3-4Subclone of NIH3T3
RCB1863GRP1^(-)DT40Ras GRP1 deficient DT40 cells
RCB1864GRP3^(-)DT40Subline of DT40 cell line, lacking RasGRP3 expression.
RCB1865GRP1^(-)/GRP3^(-)DT40Subline of DT40 cell line, lacking both of RasGRP1 and RasGRP3 expression.
RCB1866Sos1^(-)DT40Subline of DT40 cell line, lacking Sos1 expression.
RCB1867Sos2^(-)DT40Subline of DT40 cell line, lacking Sos2 expression.
RCB1868Sos1^(-)/Sos2^(-)DT40Subline of DT40 cell line, lacking both Sos1 and Sos2 expression.
RCB1869LY-ASubline of CHO-K1 cell line in which trafficking of ceramide is deficient
RCB1870LY-A/hCERTSubline of LY-A in which human CERT cDNA are expressed and trafficking of ceramide is recovered
RCB1871TL-1Human lymphoid cell line derived from Burkitt's lymphoma. Tumorigenic in nude mouse. TKG0607(Deposited from Tohoku Univ.). Application consideration
RCB1872A431Human cell line derivd from epidermoid carcinoma. TKG0182 (Deposited from Tohoku Univ.).
RCB1873JTK-LCLHuman B cell line transformed by Epstein-Barr Virus. HLA: A0206 and A2402. TKG0585 (Deposited from Tohoku Univ.).
RCB1874KOIA-LCLEBV-transformed cell line from a patient (male) with p53 germ line mutation. Mutation was noted at codon 242 (TGC→TAC) by FASAY. TKG0506 (Deposited from Tohoku Univ.).
RCB1875XPL 5Lymphoblastoid cell line established by EBV infection from XP patient, variant type. TKG0309(Deposited from Tohoku Univ.).
RCB1876211-LCL-MUC1Human B lymphoblastoid cell line (RCB2288 211-LCL) transformed with APR-MUC1 and PRC-MUC1 cDNAs. TKG0615 (Deposited from Tohoku Univ.).
RCB1878RPMI1788IgM (lambda) secreting B cell line. Established from peripheral blood lymphocytes of apparently normal 33-y-o male. HLA profile: A2, Aw33, B7, B14. TKG0464 (Deposited from Tohoku Univ.).
RCB1879PEERHuman T cell line derived from acute T cell leukemia. TKG0377 (Deposited from Tohoku Univ.).
RCB1881TL-MorHuman derived T cell line. HTLV-1 pro-virus DNA(+). TKG0369 (Deposited from Tohoku Univ.).
RCB1882BALL-1Human cell line derived from B cell leukemia. TKG0467 (Deposited from Tohoku Univ.).
RCB1884H-111-TCHuman cell line derived from gastric cancer. TKG0411 (Deposited from Tohoku Univ.). Cell growth is slow.
RCB1886Hep G2Human cell line derived from hepatocyte carcinoma. TKG0205 (Deposited from Tohoku Univ.). Information
RCB1889HEp-2Supports growth of arvovirus and measles virus. A subline of HeLa cell (HeLa contamination).TKG0403 (Deposited from Tohoku Univ.).
RCB1890MG-63Osteosarcoma cell line derived from human. High yield of IFN production by induction with poly IC, cyclohexmide, actinomycin D. Antigenically, MG-63 IFN is closely related to human fibroblast IFN.TKG0294 (Deposited from Tohoku Univ.).
RCB1891HeLa TGA subline of HeLa. 6-thioguanine resistant. TKG0204 (Deposited from Tohoku Univ.).
RCB1892SKG-IIIaCervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/. TKG0462 (Deposited from Tohoku Univ.).
RCB1894TE-1Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0252 (Deposited from Tohoku Univ.).
RCB1896TN-2Human cell line derived from neuroblastoma of adrenal gland. TKG0278 (Deposited from Tohoku Univ.).
RCB1897K562Human cell line derived from chronic myelogenous leukemia. Differentiate into mature erythrocytes.TKG0210 (Deposited from Tohoku Univ.).
RCB1898K562/AdrSubline of K562. Resistant to adriamycin. TKG0211 (Deposited from Tohoku Univ.).
RCB1900Lu99Lung giant cell carcinoma cell line derived from human. TKG0495 (Deposited from Tohoku Univ.).
RCB1901PK-59Human cell line derived from pancreatic cancer. TKG0492 (Deposited from Tohoku Univ.).
RCB1902HSC-4Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).
RCB1903OVK18Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).
RCB1904MCF7Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).
RCB1905Sq-1Human cell line derived from lung squamous cell carcinoma. Many granules are found in cytoplasma. HLA-A 11/24. TKG0301 (Deposited from Tohoku Univ.). Application consideration
RCB1907TKKKHuman cell line derived from intrahepatic bile duct cancer. TKG0456 (Deposited from Tohoku Univ.).
RCB19098305CHuman thyroid anaplastic carcinoma derived cell line. TKG0446 (Deposited from Tohoku Univ.).
RCB1911CCD-ICRabbit kidney cell line transformed by SV40 large T antigen. Derived from renal cortical collecting tubules.
RCB1912CNTRabbit kidney cell line transformed by SV40 large T antigen. Derived from renal distal tubules.
RCB1913PST-S2Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal proximal tubules.
RCB1914BBWV-22K3-9BHybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
RCB1915BBWV-22K5-12AHybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
RCB1916BBWV-22K6-2AHybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
RCB1918J#176-3.2Hybridoma producing a monoclonal antibody against mouse JDP2.
RCB1919J#214.2-2Hybridoma producing a monoclonal antibody against mouse JDP2. The antibody recognizes a truncated from of JDP2.
RCB1920J#249.1-1Hybridoma producing a monoclonal antibody against mouse JDP2.
RCB1921NRGMouse bone marrow derived fibroblast-like cells line. Differentiates to neuron.
RCB19221C7Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
RCB192313D10Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
RCB1924h1cHybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
RCB1925WA-mFibMouse stromal cell line for human lung small cell carcinoma cell line, WA-ht. Cell growth is slow.
RCB1926OT11RBP-J deficient mouse fibroblasts
RCB1927OT13Control cell line for OT11 (normal fibroblasts derived from the same mouse strain)
RCB1928KG-1aHuman cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402 (Deposited from Tohoku Univ.).
RCB1932T2Human hybrid (T and B lymphoblast) cell line. Fusion cll line between 174 and CEM.T2. This hybrid cells do not express MHC class II. HLA-A2 positive. TKG0599 (Deposited from Tohoku Univ.).
RCB1933NALM-6Human cell line derived from B cell leukemia. TKG0413 (Deposited from Tohoku Univ.).
RCB1934HUT78Human cell line derived from T cell of a patient with Sezary syndrome. Producing IL-2. TKG0375(Deposited from Tohoku Univ.).
RCB1935HPB-ALLHuman cell line derived from T cell leukemia. TKG0199 (Deposited from Tohoku Univ.).
RCB1936MOLT-4FHuman T leukemic cell line (CD4+). CR2 receptor (+). TKG0229 (Deposited from Tohoku Univ.).
RCB1938P30/OHKHuman cell line derived from T cell leukemia. TKG0463 (Deposited from Tohoku Univ.).
RCB1939NUGC-4Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).
RCB1940SH-10-TCHuman cell line derived from gastric cancer. Derived from nude mouse xenograft tumor (TKG 0338, SH-10). TKG0412 (Deposited from Tohoku Univ.).
RCB1941Li-7Human hepatoma cell line. This cell line was established from nude mouse xenograft tumor (Dr. Hirohashi., National Cancer Center, Tokyo) by Tanno, H. (Tohoku Univ., 1st Surg). AFP producing.TKG0368 (Deposited from Tohoku Univ.).
RCB1942HuH-7Human cell line derived from hepatoma. TKG0206 (Deposited from Tohoku Univ.).
RCB1943HuH-28Human cell line derived from cholangiocellular carcinoma. TKG0438 (Deposited from Tohoku Univ.).
RCB1945HSC-2Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).
RCB1947Ca SkiHuman cell line derived from uterine cervical epidermoid carcinoma. TKG0366 (Deposited from Tohoku Univ.).
RCB1949TE-5Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).
RCB1950TE-6Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. Progeny were cured by Treatments with BM Cycline and MC210. TKG0257 (Deposited from Tohoku Univ.).
RCB1951TE-15Human cell line derived from esophageal cancer (highly differentiated squamous cell carcinoma). Not transplantable to nude mouse. TKG0266 (Deposited from Tohoku Univ.).
RCB1952SCCH-26Human neuroblastoma cell line. TKG0460 (Deposited from Tohoku Univ.).
RCB1953NB-1Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486(Deposited from Tohoku Univ.).
RCB1954T98GHuman cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471 (Deposited from Tohoku Univ.).
RCB1955KMST-6Human cell line derived from embryonic fibroblasts. Characteristics Embryonal fibroblast immortalized by 60-Co irradiation (400 Rad x 1 time and 200 rad x 12 times). Non-tumorigenic.TKG0482 (Deposited from Tohoku Univ.).
RCB1960HuCCT1Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389 (Deposited from Tohoku Univ.).
RCB1963VMRC-RCWHuman renal cell carcinoma cell line. TKG0447 (Deposited from Tohoku Univ.).
RCB1965EBC-1Human lung squamous cell carcinoma cell line. TKG0481 (Deposited from Tohoku Univ.).
RCB1966S1Human cell line derived from lung cancer. Small cell carcinoma. TKG0244 (Deposited from Tohoku Univ.). Application consideration
RCB1967LU65Human lung carcinoma cell line. TKG0442 (Deposited from Tohoku Univ.).
RCB1970LK-2Human lung squamous cell carcinoma cell line. TKG0494 (Deposited from Tohoku Univ.).
RCB1971Lu99BHuman lung giant cell carcinoma cell line. TKG0496 (Deposited from Tohoku Univ.).
RCB1972PK-1Human pancreatic carcinoma cell line. RCB2138 was derived from the same patient. TKG0239(Deposited from Tohoku Univ.).
RCB1973PK-45HHuman pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491 (Deposited from Tohoku Univ.).
RCB1974SASHuman cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470 (Deposited from Tohoku Univ.).
RCB1975HSC-3Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484 (Deposited from Tohoku Univ.).
RCB1976Ca9-22Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485(Deposited from Tohoku Univ.).
RCB1980CCRF-CEMHuman cell line derived from T cell leukemia. TKG0563 (Deposited from Tohoku Univ.).
RCB1981HD-Mar2Human cell line derived from Hodgkin's lymphoma. TKG0198 (Deposited from Tohoku Univ.).
RCB1988TE-9Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).
RCB1990KUSA-H1Mouse bone marrow-derived stromal cells.
RCB1991KUSA-OMouse multipotent mesenchymal cells. Derived from bone marrow.
RCB1992UV♂1dMouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.
RCB1993UV♀1AMouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.
RCB1994UV♀2Mouse vascular endothelial cell line. Transformed by ultraviolet.
RCB1995UV·BAL-1.1Mouse skin derived cell line. Induced by ultra-violet irradiation.
RCB1996UV·BAL-2.1DMouse skin derived cell line. Induced by ultra-violet irradiation.
RCB1997UV·B6-1.1Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.
RCB1998UV·B6-2.1AMouse skin derived cell line. Induced by ultra-violet irradiation.
RCB1999UV·B6-4.1Mouse fibroblast-like cell line derived from skin. C57BL/6 strain.Induced by ultra-violet irradiation.
RCB2000UV·B6-5.1Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.
RCB2013GMR3Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GD3 gangliosides).
RCB2014GMB7Hybridoma producing a monoclonal antibody against GD2 gangliosides (b-pathway gangliosides).
RCB2015GMR8Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GM3 gangliosides).
RCB2016AMR19Hybridoma producing a monoclonal antibody against ganglioside lactones.
RCB2021GGR41Hybridoma producing a monoclonal antibody against GQ1ba gangliosides.
RCB2024UV·BAL-3.3Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Neuron-like)
RCB2025UV·BAL-5.4GMouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Epithelial-like)
RCB2026UV·BAL-6.1EMouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2027UV·BAL-7.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2028UV·BAL-8.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2029UV·BAL-8.1CMouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2030UV·BAL-12.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2031UV·BAL-13.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2032UV·BAL-14.2Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2033UV·BAL-15.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2034UV·BAL-16.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2035UV·BAL-17.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2036UV·BAL-18.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2037NGR54Hybridoma producing a monoclonal antibody against 2-3NeuAca-nLc4Cer gangliosides.
RCB2039NMR52Hybridoma producing a monoclonal antibody against nLc4Cer.
RCB2040NGR50Hybridoma producing a monoclonal antibody against SGPG.
RCB2041AMR20Hybridoma producing a monoclonal antibody against GalCer.
RCB2042AGB43Hybridoma producing a monoclonal antibody against Sulfatide.
RCB2046BMR26Hybridoma producing a monoclonal antibody against Globoside.
RCB2048OMB4Hybridoma producing a monoclonal antibody against N-linked neutral oligosaccharides of glycoproteins.
RCB2049OMR5Hybridoma producing a monoclonal antibody against F1-linked neutral oligosaccharides of glycoproteins.
RCB2050OMR6Hybridoma producing a monoclonal antibody against M1-linked neutral oligosaccharides of glycoproteins.
RCB2053UV·C3H-3.3Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.
RCB2056UV·C3H-8.2Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.
RCB2057UV·BAL-19.1AMouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2058UV·BAL-20.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2059UV·BAL-21.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2060UV·BAL-23.1Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2061UV·C3B6-1.1Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2062UV·C3B6-1.1CMouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2065UV·CB6-2.1FMouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2066UV·CB6-3.4BMouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2067UV·CB6-4.1DMouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2068UV·CB6-4.1FMouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2070UV·CB6-5.2Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2071UV·CB6-5.2BMouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2072UV·CB6-6.1Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2073UV·CB6-6.1BMouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2074UV·CC3-11.1Mouse fibroblast-like cell line derived from skin. (BALB/cxC3H)F1 strain. Induced by ultra-violet irradiation.
RCB2076HasChinese hamster cell line. Epithelial-like adherent cells.
RCB2078FU-RPNT-2Human primitive neuroectodermal tumor cell line derived from kidney.
RCB2081KUSA-A1Mesenchymal stem cell line derived from C3H/He mouse strain.
RCB2082103-LCLHuman B cell line transformed by Epstein-Barr Virus. TKG0614 (Deposited from Tohoku Univ.).
RCB2083141-LCLHuman B cells transformed by Epstein-Barr virus. RCB2541 was derived from the same patient.TKG0611 (Deposited from Tohoku Univ.).
RCB2084TALL-1Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).
RCB2088Kato IIIHuman cell line derived from gastric cancer. Signet ring carcinoma. TKG0213 (Deposited from Tohoku Univ.).
RCB209287-5Human cell line derived from lung cancer. Small cell carcinoma. TKG0503 (Deposited from Tohoku Univ.).
RCB2093II-18Human cell line derived from lung cancer. Adenocarcinoma. TKG0177 (Deposited from Tohoku Univ.).
RCB2094MIA Paca2Human cell line derived from pancreatic cancer. TKG0227 (Deposited from Tohoku Univ.).
RCB2095PANC-1Human cell line derived from pancreatic cancer. Ductal origin. TKG0606 (Deposited from Tohoku Univ.).
RCB2097TE-4Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma.TKG0255 (Deposited from Tohoku Univ.).
RCB2098TE-8Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259 (Deposited from Tohoku Univ.).
RCB2099TE-10Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma.TKG0261 (Deposited from Tohoku Univ.).
RCB2100TE-11Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262 (Deposited from Tohoku Univ.).
RCB2101TE-14Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0265 (Deposited from Tohoku Univ.).
RCB2102HO-1-u-1Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455 (Deposited from Tohoku Univ.).
RCB21038505CHuman cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma.TKG0439 (Deposited from Tohoku Univ.).
RCB2104HuO-3N1Human cell line derived from osteosarcoma. TKG0452 (Deposited from Tohoku Univ.).
RCB2105D98-AH2Human cell line derived from cervical cancer. The cells were converted to HGPRT(-). A subline of HeLa cell. TKG0191 (Deposited from Tohoku Univ.).
RCB2106ME-180Human cell line derived from cervical cancer. TKG0437 (Deposited from Tohoku Univ.).
RCB2107TN-1Human cell line derived from neuroblastoma formed at adrenal gland. TKG0277 (Deposited from Tohoku Univ.).
RCB2108NH-12Human cell line derived from neuroblastoma. TKG0448 (Deposited from Tohoku Univ.).
RCB2109NH-6Human cell line derived from neroblastoma of adrenal gland. TKG0468 (Deposited from Tohoku Univ.).
RCB2110YKG1Human cell line derived from glioblastoma. TKG0453 (Deposited from Tohoku Univ.).
RCB2111K562/VinSubline of K562 cell line. Resistant to vincristine. TKG0212 (Deposited from Tohoku Univ.).
RCB2112KUM4Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2113KUM6Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2114KUM7Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2115KUM9Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2116TSt-4Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors.
RCB2117TSt-4/GMurine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/G-DLL1. By retorviral transduction, EGFP is expressed.
RCB2118TSt-4/G-DLL1Original murine mesenchymal cell line was derived from fetal thymus tissue. DLL1 gene was retrovirally introduced. Can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. EGFP was also introduced, and is expressed as a marker.
RCB2119TSt-4/NOriginal murine mesenchymal cell line was derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/N-DLL1. By retorviral transduction, huma NGF receptor is expressed.
RCB2120TSt-4/N-DLL1Original murine mesenchymal cell line was derived from fetal thymus tissue. By retrovirally introducing DLL1 gene, this cell line can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. Human NGF receptor is also introduced, and is expressed as a marker on cell surface.
RCB2125BmN4-DRSilkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration
RCB2126BmN4-IRSilkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration
RCB2127COLO205Human cell line derived from colon cancer. Derived from ascites metastasis. Cell growth is slow.TKG0457 (Deposited from Tohoku Univ.).
RCB2128A-THP-1Human cell line derived from acute monocytic leukemia. Activeated macrophage activity (+), obtained from long passage of THP-1 (RCB1189 THP-1) cell line. TKG0296 (Deposited from Tohoku Univ.).
RCB2133S2Human cell line derived from lung cancer. Small cell carcinoma. TKG0245 (Deposited from Tohoku Univ.).Application consideration
RCB213486-2Human cell line derived from lung cancer. Large cell carcinoma. TKG0181 (Deposited from Tohoku Univ.).
RCB2135NIH:OVCAR-3Human cell line derived from adenocarcinoma of ovary. TKG0602 (Deposited from Tohoku Univ.).
RCB2136YST-1Human cell line derived from schwannoma. TKG0454 (Deposited from Tohoku Univ.).
RCB2138KLM-1Human cell line derived from pancreatic cancer. RCB1972 was derived from the same patient.TKG0490 (Deposited from Tohoku Univ.).
RCB2141PK-45PHuman cell line derived from pancreatic carcinoma. RCB1973 was derived from the same patient.TKG0493 (Deposited from Tohoku Univ.).
RCB2143DU145Human cell line derived from brain metastasis of prostate carcinoma. TKG0604 (Deposited from Tohoku Univ.).
RCB2144LNCap.FGCHuman cell line derived from prostate adenocarcinoma. Derived from lymph node metastasis.TKG0603 (Deposited from Tohoku Univ.).
RCB2145PC-3Human cell line derived from bone metastasis of prostatic cancer. TKG0600 (Deposited from Tohoku Univ.).
RCB2146WERI-Rb-1Human cell line derived from retinoblastoma. TKG0601 (Deposited from Tohoku Univ.).
RCB2147KUM3Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2148KOPMouse fibroblast-like cell line lacking p38 MAP kinase expression.
RCB2149RKOPSubline of KOP cell line, expressing FLAG-tagged p38 MAP kinase. Zeocin-resistant.
RCB2150EKOPSubline of KOP cell line, expressing FLAG-tagged EXIP. Zeocin-resistant.
RCB2151ZKOPSubline of KOP cell line. Zeocin-resistant.
RCB2163UE6E7-16Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6 and E7. RCB2152- RCB2163 are derived from the same bone marrow.
RCB2202293THuman cell line expressing SV40 large T antigen abundantly.
RCB2203TFS-2Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
RCB2204TFS-4Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
RCB2205NCC-RbC-39Human retinoblastoma cell line.
RCB2206NCC-RbC-51Human retinoblastoma cell line derived from cervical lymph node metastasis.
RCB2208NCC-RbC-54Human cell line derived from retinoblastoma.
RCB2212NCC-RbC-59Human cell line derived from retinoblastoma. Cell growth is slow.
RCB2213NCC-RbC-60Human cell line derived from retinoblastoma.
RCB2214NCC-RbC-67Human cell line derived from retinoblastoma.
RCB2217NCC-RbC-83Human cell line derived from retinoblastoma.
RCB2218NCC-RbC-92Human cell line derived from retinoblastoma.
RCB2219NCC-RbC-T1Human cell line derived from retinoblastoma.
RCB2223NCC-OvC-K119Human cell line derived from ovarian cancer.
RCB2224NCC-StC-K140Human cell line derived from stomach cancer.
RCB2225JHUEM-14Human cell line derived from uterus cancer. Endometrioid adenocarcinoma. Application consideration
RCB2226JHOC-9Human cell line derived from ovary cancer. Clear cell carcinoma. Application consideration
RCB2227JMSU1Human cell line derived from urinary bladder carcinoma. Derived from ascites.
RCB2229HS-Os-1Human cell line derived from osteosarcoma.
RCB2230HS-Sch-2Human cell line derived from malignant peripheral nerve sheath tumor (MPNST).
RCB2231HS-SY-IIHuman cell line derived from synovial sarcoma. Application consideration
RCB2233HE12Human fibroblast-like cells derived from embryo. Not immortalized. Application consideration
RCB2234HE13Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2237HE16Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2238HE18Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2239HE19Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2240HE21Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2241HE22Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2244HE27Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2245HE28Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2246HE29Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2247HE30Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2248HE31Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2249HE32Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2250HE33Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2251HE34Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2253HKb20Subline of HEK293 cell line, expressing BtR175b (Cry 1Aa receptor).
RCB2254HE36Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2256HE37Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2257HE38Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2258HE39Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2259HE40Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2260HE41Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2261HE42Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2262HE46Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2263HE47Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2264HE48Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2265HE49Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2266HE50Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2267HE51Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2268HE52Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2269HE53Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2270HE54Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2271HE55Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2273HE57Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2277GSSHuman gastric cancer cell line derived from metastasis at liver.
RCB2278GSUHuman cell line derived from gastric cancer. Established from the cells in ascites.
RCB2279WA-hTHuman cell line derived from lung cancer. Small cell carcinoma. Mouse WA-mFib cells are the stromal cells for this cell line.
RCB2280HCE-TSV40-Adeno vector transformed cornea cells. 64kD keratin producing. Choleratoxin-free medium.
RCB2281T3M-12Human lung small cell carcinoma cell line. ADH producing.
RCB2282701-LCLHuman cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0610(Deposited from Tohoku Univ.).
RCB2283277-LCLHuman B cells transformed by Epstein-Barr virus. TKG0609 (Deposited from Tohoku Univ.).
RCB2286XPL 17Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0311 (Deposited from Tohoku Univ.).
RCB2287XPL 20Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0313 (Deposited from Tohoku Univ.).
RCB2288211-LCLHuman cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0616(Deposited from Tohoku Univ.).
RCB2292ACC-MESO-1Human malignant pleural mesothelioma cell line.
RCB2293ACC-MESO-4Human malignant pleural mesothelioma cell line.
RCB2295KUM10Mouse mesenchymal cell line derived from bone marrow.　C57/B6.
RCB2296CARMA1^(-)DT40Subline of DT40 cell line, lacking CARMA1 expression.
RCB2297PKCβ^(-)DT40Subline of DT40 cell line, lacking PKC-β expression.
RCB2298TAK1^(-)DT40Subline of DT40 cell line, lacking TAK1 expression.
RCB2299RMC-1Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2300RMC-2Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2301RMC-3Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2302RMC-6Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2303RMC-11Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2304RMC-17Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2305MIH5(GIT)Hybridoma producing a monoclonal antibody against mouse B7-H1.
RCB2306PC3.1Hybridoma producing monoclonal antibody against latexin.
RCB2307T1.7Hybridoma producing monoclonal antibody against C-terminal peptide of rat GSK3-beta.
RCB2308802C11Hybridoma producing monoclonal antibody against MuSc.
RCB2309JFP-J1Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
RCB2310JFP-J5Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
RCB2311JFP-K2Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
RCB2312859H5Hybridoma producing monoclonal antibody against bacterial unknown molecule. Rat IgG2a monoclonal antibody.
RCB2313884F11Hybridoma producing monoclonal antibody against mouse apolipoprotein E.
RCB2314F9/LM10Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
RCB2315F9/LM(1+10)Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
RCB2316AB1Hybridoma producing monoclonal antibody against GD1b gangliosides.
RCB2317AC1Hybridoma producing monoclonal antibody against GD1c gangliosides.
RCB2318P19.CL6Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear efficiently.
RCB2322KUM5Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB23239-15CMouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2324MIH5(RPMI)Hybridoma producing a monoclonal antibody against mouse B7-H1. Possible to culture in RPMI1640 medium.
RCB2326CHO-AA8A subline of the CHO-K1 cell line. Widely used for the isolation of repair-deficient mutants. Useful for gene mutation assays at the APRT and HPRT loci.
RCB2327EM-9A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC1 gene deficient.
RCB2328irs1SFA subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC3 gene deficient.
RCB2329V-3A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC7(DNA-PK) gene deficient.
RCB2330CHO-K1Chinese hamster ovary cell line. Widely used for the isolation of mutants by mutagenesis.
RCB2331XR-1A subline of the CHO-K1 cell line. X-ray-sensitive mutant. XRCC4 gene deficient.
RCB2332V79-4A subline of the V79 cell line following cloning. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
RCB2335V-E5X-ray-sensitive mutant derived from the V79 cell line. XRCC8 gene deficient.
RCB2336V-G8A subline of the V79 cell line. X-ray-sensitive mutant. XRCC8 gene deficient.
RCB2337V79BA subline of the V79 cell line. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
RCB2338XR-V9B-4A subline of the V79B cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
RCB2339XR-V15BA subline of the V79 cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
RCB2341NCR-G1Human cell line derived from embryonal carcinoma of testis.
RCB2342NCR-G2Human cell line derived from embryonal carcinoma of testis.
RCB2343NCR-G3Human cell line derived from embryonal carcinoma of testis.Application consideration
RCB2344NCR-G4Human cell line derived from embryonal carcinoma of testis.
RCB2345EEBHuman cell line derived from erythroblastic leukemia.
RCB2346NMFH-1Human cell line derived from myxofibrosarcoma.
RCB2347NMS-2Human cell line derived from malignant peripheral nerve sheath tumor.
RCB2348NOS-10Human cell line derived from osteosarcoma.
RCB2351OGU1Human cell line derived from primary effusion lymphoma (PEL). Application consideration
RCB2352633Human lung cancer cell line expressing capsid protein of human adenovirus.
RCB2354293gpRetroviral vector packaging cell line expressing MoMLV (Moloney murine leukemia virus) gag/pol. Production of high titer retrovirus by cotransfection of envelope and vector plasmids.
RCB2355HeLa CD4+Clone1022A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene.
RCB2356HeLa-CD4-LTR-β-galA subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene. One copy of the HIV-1 LTR (nt-138 to +80) linked to the β-galactosidase gene is integrated.
RCB2358HLtatA subline of the HeLa cells. HeLa cells contained stably integrated copies of the HIV-1 LTR promoter linked to a synthetic tat gene.
RCB2360HS-ES-2MHuman cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.
RCB2361HS-ES-2RHuman cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.
RCB2362HS-PSSHuman cell line derived from malignant peripheral nerve sheath tumor.
RCB2364HS-ES-1Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-2M, 2R cell lines.
RCB2365JHONAHuman cell line derived from ovarian squamous cell cancer. Application consideration
RCB2367KT01Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
RCB2368KT02Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
RCB2369KT03Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
RCB2372KT06Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
RCB2375KT09Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
RCB2376KT10Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
RCB2377KT11Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
RCB2378KT12Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
RCB2379KT13Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that seam cell.
RCB2380KT14Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx basement membrane.
RCB2381KT16Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
RCB2382KT17Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
RCB2383KT18Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
RCB2386KT21Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on intestine.
RCB2388KT23Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on nuclear membrane.
RCB2389KT26Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome.
RCB2390KT27Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on hypodermis.
RCB2392KT29Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
RCB2393KT30Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
RCB2395KT32Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and pharynx.
RCB2400KT54Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome and P-granule.
RCB2402STIM1^(-)DT40Subline of DT40 cell line, lacking STIM1 expression.
RCB2403MG6Mouse microglial cell line immortalized by a replication-deficient retroviral vector containing human c-myc gene. No significant production of infectious viral particles from MG6 cells was confirmed by bioassay using SC-1 cells.
RCB2530A172Human cell line derived from glioblastoma. TKG0183 (Deposited from Tohoku Univ.).
RCB2531CB-3512Human cell line derived from B cells in umbilical cord blood. Transformed by EB virus. TKG0305(Deposited from Tohoku Univ.).
RCB2532HuO 9N2 (O9N2)Human cell line derived from osteosarcoma. TKG0451 (Deposited from Tohoku Univ.).
RCB2534M-MOKHuman cell line derived from megakaryoblastic leukemia. TKG0458 (Deposited from Tohoku Univ.).
RCB2535OVK18#102Human cell line derived from ovarian endometrioid carcinoma, subclone of RCB1903. TKG0357(Deposited from Tohoku Univ.).
RCB2536T24Human cell line derived from bladder cancer. Transitional cell carcinoma. TKG0443 (Deposited from Tohoku Univ.).
RCB2537TFK-1Human cell line derived from extrahepatic bile duct carcinoma. TKG0367 (Deposited from Tohoku Univ.).
RCB2539XPL 19Human B cell line derived from xeroderma pigmentosum (XP) patient and transformed by Epstein-Barr Virus. TKG0312 (Deposited from Tohoku Univ.).
RCB2540XPL 24Human cell line derived from B cells of Xeroderma pigmentosum (XP) patient. Transformed by EB virus. TKG0314 (Deposited from Tohoku Univ.).
RCB2541141-LCL-MUC1Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. RCB2083 was derived from the same patient. TKG0634 (Deposited from Tohoku Univ.).
RCB2610FELV3281-ADCat cell line derived from lymphoma.
RCB2611MDCK-ADDog cell line derived from kidney.
RCB2614KLN205-MUC1Mouse cell line derived from lung squamous cell carcinoma. TKG0473 (Deposited from Tohoku Univ.).
RCB2618BCL1-B20Mouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.).
RCB2619L929Mouse fibroblast-like cell line. TKG0217 (Deposited from Tohoku Univ.).
RCB2620C-1300N18Mouse cell line derived from neuroblastoma. TKG0307 (Deposited from Tohoku Univ.). Application consideration
RCB2621M1(D+)Mouse cell line derived from meyloid leukemia. TKG0319 (Deposited from Tohoku Univ.).
RCB2623KLN205Mouse cell line derived from lung squamous cell carcinoma. TKG0214 (Deposited from Tohoku Univ.).
RCB2627BOY-12EHuman cell line derived from urinary bladder carcinoma. TKG0641 (Deposited from Tohoku Univ.).
RCB2630B16F10Mouse cell line derived from melanoma. TKG0348 (Deposited from Tohoku Univ.).
RCB2633MM46 CEA1-2Mouse cell line derived from mammary carcinoma. TKG0597 (Deposited from Tohoku Univ.).
RCB2634MM46-APR-MUC1 cl.1Mouse cell line derived from mammary carcinoma. Expressing human MUC1 (APR-MUC1) exogenously. TKG0595 (Deposited from Tohoku Univ.).
RCB2637A4Subline of NIH/3T3 transformed with an active type c-erb B-2 (V-659 was changed to E659). c-erb B-2 prouct (+). G418 resistant. TKG0298 (Deposited from Tohoku Univ.).
RCB2638B16/BL6Mouse cell line derived from melanoma.　 TKG0598 (Deposited from Tohoku Univ.).
RCB2639NB2aMouse cell line derived from neuroblastoma. TKG0509 (Deposited from Tohoku Univ.).
RCB2640G-415Human cell line derived from gallbladder carcinoma. TKG0642 (Deposited from Tohoku Univ.).
RCB2642MUSSMouse cell line derived from spontaneous malignant fibrous histiocytoma. A/J strain. TKG0497(Deposited from Tohoku Univ.).
RCB2643F9Mouse cell line derived from embryonal carcinoma. 129 strain. TKG0519 (Deposited from Tohoku Univ.). Application consideration
RCB2648D4A subline of the NIH/3T3 cell line. NIH/3T3 cell line transfected with wild type c-erb B2 gene with carboxyl-terminal deletion. Swiss strain.TKG0300(Deposited from Tohoku Univ.). Cell growth is slow. TKG0300 (Deposited from Tohoku Univ.).
RCB2649B16F1Mouse cell line derived from melanoma. C57BL/6J strain. TKG0347 (Deposited from Tohoku Univ.).
RCB2651JLS-V9Mouse cell line derived from bone marrow. Fibroblast-like cells. BALB/c strain. TKG0355 (Deposited from Tohoku Univ.).
RCB2652J774-1Mouse cell line derived from ascites. Macrophage-like cells. BALB/c strain. TKG0208 (Deposited from Tohoku Univ.).
RCB2657Colon-26Mouse cell line derived from colon cancer. BALB/c strain. TKG0518 (Deposited from Tohoku Univ.).
RCB2660MEDEP-E14Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, E14TG2a. Epo(Erythropoietin) dependent.
RCB2686JTC-35Bovine granulosa cell line.
RCB2691MEDEP-E14 clone 4A subclone of MEDEP-E14(RCB2660) following cloning procedure.
RCB2692MEDEP-BRC4-1Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF(Stem cell factor) and Dex(dexamethasone) dependent.
RCB2693MEDMC-NT2Mouse cell line possessing the characteristics of mast cells. IL-3 (Interleukin-3) dependent.
RCB2694MEDMC-BRC6Mouse cell line derived from mouse ES cell line, BRC6 (AES0010). Mast cell-like cells. SCF (Stem cell factor) and IL-3 (Interleukin-3) dependent. C57BL/6 strain.
RCB2695RD-C2Mouse osteoblast-like cell line derived from Runx2 deficient mouse.
RCB2696RD-C6Mouse osteoblast-like cell line derived from Runx2 deficient mouse.
RCB2700PK-8Human cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.).
RCB27092F8Hybridoma producing monoclonal antibody against oxitocin receptor.
RCB2710Atg5^(+/+)MEFMouse embryonic fibroblasts. Wild type control for RCB2711.
RCB2711Atg5^(-/-)MEFMouse embryonic fibroblasts lacking Atg5 gene expression.
RCB2712MAECMouse cell line derived from aorta of p53-deficient mouse. Epithelial like.
RCB2718MT-7Rat cell line derived from fibrous histiocytoma. After cloning.
RCB2719MT-10Rat cell line derived from fibrous histiocytoma. After cloning.
RCB2720MT-R8A subline of MT-8, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
RCB2721MT-R9A subline of MT-9, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
RCB2722MT-10RA subline of MT-10, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
RCB2723MT-PRA subline of MT-P, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin. The parent cell line, MT-P, is also deposited but not available yet.
RCB2724KB-D8Rat cell line derived from dendritic cell carcinoma in thymus.
RCB2725KJ-ARat cell line derived from malignant fibrous histiocytoma.
RCB2726KE-F11Rat cell line derived from malignant schwannoma.
RCB2727RY-B-E3Rat cell line derived from endometrial stromal sarcoma.
RCB2728LY-H12Rat non-neoplastic cell line derived from malignant peripheral nerve sheath tumor.
RCB2729LY-PPB6Rat cell line derived from malignant peripheral nerve sheath tumor.
RCB27405-WASPHybridoma producing monoclonal antibody against WASP (Wiskott-Aldrich syndrome protein).TKG0631 (Deposited from Tohoku Univ.).
RCB2745A20Mouse cell line derived from lymphoma. Balb/c strain. TKG0571 (Deposited from Tohoku Univ.).
RCB2758LAGMouse cell line derived from connective tissue. Fibroblast-like. C3H strain. TKG0218 (Deposited from Tohoku Univ.).
RCB2766Morris 5123D-TCRat (Buffalo) cell line derived from hepatoma. TKG0365 (Deposited from Tohoku Univ.).
RCB2767NIH/3T3Mouse fibroblast-like cell line. TKG0299 (Deposited from Tohoku Univ.).
RCB2776P388Mouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0326 (Deposited from Tohoku Univ.).
RCB2782RBL 2H3Rat cell line derived from basophilic leukemia cells. TKG0321 (Deposited from Tohoku Univ.).
RCB2783RGC-6Rat cell line derived from glioma induced by N-nitrosomethylurea. TKG0242 (Deposited from Tohoku Univ.).
RCB2784RL♂1(Gloria)Mouse cell line derived from lymphoid tumor. BALB/c strain. TKG0292 (Deposited from Tohoku Univ.).
RCB2799YAC-1Mouse cell line derived from lymphoma. A/Sn strain. TKG0387 (Deposited from Tohoku Univ.).
RCB2800PC12-F7A subline of PC-12 lacking synaptotagmin-1.
RCB2801PC12-G11A subline of PC-12 expressing synaptotagmin-1, a control cell line for PC12-F7.
RCB2806MSK-C5.8GRat cell line derived from osteosarcoma. F344 strain.
RCB2808Odf2-deficient F9 cellsA subline of mouse ES cell line, F9 (129), lacking Odf2.
RCB2809CH12F3-2AMouse cell line derived from B cell lymphoma.
RCB28117F9 (hybridoma)Hybridoma. Anti-Rat Carboxypeptidase M MoAb producing.
RCB2812HeLa/FucciA subline of the HeLa cell line expressing Fucci, a cell cycle marker. Cell line name : HeLa/Fucci #4.Important notice regarding nomenclature of Fucci.
RCB2813NMuMG/FucciA subline of the NMuMG cell line expressing Fucci, a cell cycle marker. Cell line name : NMuMG/Fucci #1.Important notice regarding nomenclature of Fucci.
RCB2815P20.1Hybridoma producing monoclonal antibody against a peptide, GYPGQV.
RCB2816A110LHuman cell line derived from lung adenocarcinoma cells.
RCB2817A529LHuman cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/.
RCB2818B1203LHuman cell line derived from lung adenocarcinoma. HLA A2402/2402, B5201/5401, C0102/1202.
RCB2819C831LHuman cell line derived from lung large cell carcinoma. HLA A0206/2601, B0702/3501, Cw0702/0801.
RCB2830OMC-2Human cell line derived from endometrial adenocarcinoma. Cell growth is slow.
RCB2831DEOC-1Human cell line derived from malignant melanoma. Cell growth is slow.
RCB2832OMC-9Human cell line derived from endometrial stromal sarcoma.
RCB2833L23immoHuman immortalized cell line derived from MRC5 cells.
RCB2834L12.9-2(1)Human immortalized cell line derived from MRC5 cells.
RCB284343LSomatic tumor hybrid (fusion cell between C3H mammary tumor FM3A#2 and 8-Ag resistant L cell). This hybrid tumor cells induce resistance to MM Ag positive tumor cells. TKG0381 (Deposited from Tohoku Univ.).
RCB2844L1210 TGR4Mouse cell line derived from leukemia. Resistant to 6TG (10 microgram/ml). DBA/2 strain. TKG0478(Deposited from Tohoku Univ.).
RCB2845L1210-5FU-R-TCMouse cell line derived from leukemia. Lymphoblastoid cells. DBA/2 strain. TKG0409 (Deposited from Tohoku Univ.).
RCB2846LAG-MUC1A subline of LAG (RCB2758) expressing MUC1. 8-Ag resistant. TKG0466 (Deposited from Tohoku Univ.).
RCB2848OTT6050(B)Mouse cell line derived from testicular teratoma. This cell line was established by inoculation of tibia (6 days old) to A/He x 129/sv mouse testis. Primary tumor was developed in testis. TKG0330(Deposited from Tohoku Univ.).
RCB2852TSA8Mouse cell line derived from erythroleukemia cells transformed by Friend leukemia virus. TKG0370(Deposited from Tohoku Univ.).
RCB2853WEHI-3BMouse cell line derived from myelomonocytic leukemia cells. BALB/c strain. TKG0584 (Deposited from Tohoku Univ.).
RCB2854C6Rat cell line derived from glial cell tumor induced by N-nitrosomethylurea. TKG0589 (Deposited from Tohoku Univ.).
RCB2859K-251Rat cell line derived from hepatoma cells in ascites. TKG0130 (Deposited from Tohoku Univ.).
RCB2860MRMT-1Rat cell line derived from mammary carcinoma. TKG0132 (Deposited from Tohoku Univ.).
RCB2862SLCRat cell line derived from lung cancer. TKG0135 (Deposited from Tohoku Univ.).
RCB2863N14.5Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
RCB2864OLP6Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
RCB2867HeLa/Fucci2A subline of the HeLa cell line expressing Fucci2, a cell cycle marker. Cell line name : HeLa/Fucci2 #3. Important notice regarding nomenclature of Fucci.
RCB2868NMuMG/Fucci2A subline of the NMuMG cell line expressing Fucci2, a cell cycle marker. Cell line name : NMuMG/Fucci2 #5. Important notice regarding nomenclature of Fucci.
RCB2869CHO-K1A subline of CHO cells. Require proline. TKG0328 (Deposited from Tohoku Univ.).
RCB2896JLS-V9 6TGMouse cell line derived from bone marrow. Fibroblast-like. 6TG resistant. BALB/c strain. TKG0350(Deposited from Tohoku Univ.).
RCB2899S180-Kumamoto-TCMouse cell line derived from Swiss Webster Sarcoma 180. CFW strain. TKG0637 (Deposited from Tohoku Univ.).
RCB2900S180-Meiji-TCMouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0672 (Deposited from Tohoku Univ.).
RCB2901S180-NCC-TCMouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0638 (Deposited from Tohoku Univ.).
RCB2904WEHI164RMouse cell line derived from fibrosarcoma. TNF resistant. BALB/c strain. TKG0281 (Deposited from Tohoku Univ.).
RCB2905WEHI164SMouse cell line derived from fibrosarcoma. TNF sensitive. BALB/c strain. TKG0282 (Deposited from Tohoku Univ.).
RCB2908AH272-TCRat cell line derived from hepatoma cells in ascites. TKG0535 (Deposited from Tohoku Univ.).
RCB2909Walker256-TCRat cell line derived from mammary carcinoma. TKG0565 (Deposited from Tohoku Univ.).
RCB2910LY-6-TCRat cell line derived from sarcoma cells in ascites. TKG0648 (Deposited from Tohoku Univ.).
RCB2911MEDEP-BRC5Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC5 (AES0009). SCF(Stem cell factor) dependent.
RCB2924OP9/GSubline of OP9 cell line, expressing EGFP. Cell growth is slow.　See RCB2117 TSt-4/G.
RCB2925OP9/G-DLL1Subline of OP9 cell line, expressing DLL1 and EGFP. Cell growth is slow. See RCB2118 TSt-4/G-DLL1.
RCB2926OP9/NSubline of OP9 cell line, expressing human NGF receptor. Cell growth is slow. See RCB2119 TSt-4/N.
RCB2927OP9/N-DLL1Subline of OP9 cell line, expressing DLL1 and human NGF receptor. See RCB2120 TSt-4/N-DLL1.
RCB29316E2Hybridoma cell line expressing anti-human SSEA-4 monoclonal antibody.
RCB2932MEDEP-BRC4-2Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF (Stem cell factor) and Dexamethasone dependent. C57BL/6 strain.
RCB2942OLHNI-2Medaka cell line derived from HNI strain.
RCB2943OLHdrR-e3Medaka cell line derived from HdrR strain.
RCB2944OLCAB-e31Medaka cell line.
RCB2945DIT29Medaka cell line derived from hepatoma cells.
RCB2946OLCAB-e3Medaka cell line.
RCB2979HCT116Human cell line derived from colon cancer.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2980HCT116-XRCC4(+/-)Subline of HCT116 cell line lacking XRCC4 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2981HCT116-XRCC4(-/-)Subline of HCT116 cell line lacking XRCC4 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2982HCT116-RAD18(+/-)Subline of HCT116 cell line lacking RAD18 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2983HCT116-RAD18(-/-)Subline of HCT116 cell line lacking RAD18 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2984HCT116-ARTEMIS(+/-)Subline of HCT116 cell line lacking ARTEMIS gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2985HCT116-ARTEMIS(-/-)Subline of HCT116 cell line lacking ARTEMIS gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2986HCT116-MDC1(+/-)Subline of HCT116 cell line lacking MDC1 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2987HCT116-MDC1(-/-)Subline of HCT116 cell line lacking MDC1 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2988HCT116-REV1(+/-)Subline of HCT116 cell line lacking REV1 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2989HCT116-REV1(-/-)Subline of HCT116 cell line lacking REV1 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2990HCT116-REV3L(+/-)Subline of HCT116 cell line lacking REV3L gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2991HCT116-KU70(+/-)Subline of HCT116 cell line lacking Ku70 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2992HCT116-DNAPKcs(+/-)Subline of HCT116 cell line lacking DNAPKcs gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2993HCT116-POLM(+/-)Subline of HCT116 cell line lacking DNA polymerase m gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2994HCT116-LIG3(+/-)Subline of HCT116 cell line lacking Ligase 3 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2995HCT116-LIG4(+/-)Subline of HCT116 cell line lacking Ligase 4 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2996HCT116-53BP1(+/-)Subline of HCT116 cell line lacking 53BPI gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2997H414Subline of HCT116 cell line which has intact DNA mismatch repair gene (hMLH1).
RCB2998H414-RAD18(+/-)Subline of H414 cell line lacking RAD18 gene in one allele.
RCB2999H414-RAD18(-/-)Subline of H414 cell line lacking RAD18 gene in both alleles.
RCB3000H414-MDC1(+/-)Subline of H414 cell line lacking MDC1 gene in one allele.
RCB3001H414-MDC1(-/-)Subline of H414 cell line lacking MDC1 gene in both alleles.
RCB3002H414-LIG4(+/-)Subline of H414 cell line lacking Ligase 4 gene in one allele.
RCB3007MOPC-70AMouse cell line derived from myeloma. This cell line was established from a cell line maintained by in vivo transplantation. TKG0167 (Deposited from Tohoku Univ.).
RCB3008NC37HGPRT(-), resistant to ouabain, partner cells for human B hybridoma. Ig nonproducer, human B lymphoblastoid cell line. This line and Raji (TKG0371)are derived from the same individual. TKG0232 (Deposited from Tohoku Univ.).
RCB3010RPMI8226Human cell line derived from myeloma. IgG producer. TKG0243 (Deposited from Tohoku Univ.).
RCB3052JurkatHuman T cell leukemia. IL-2 receptor (-). Progeny were cured by Treatments with BM Cycline and MC210. TKG0209 (Deposited from Tohoku Univ.).
RCB3515JLS-V9 BudRMouse cell line derived from bone marrow. Fibroblast-like. BudR resistant. BALB/c strain. TKG0356(Deposited from Tohoku Univ.).
RCB3530B901LHuman cell line derived from lung adenocarcinoma cells.
RCB3531A904LHuman cell line derived from lung large cell carcinoma cells.
RCB3532A129LHuman cell line derived from lung adenocarcinoma cells.
RCB3576Aska-SSHuman cell line derived from synovial sarcoma.
RCB3577Yamato-SSHuman cell line derived from synovial sarcoma.
RCB3586hPSC-1Human cell line derived from choronic pancreatitis. Pancreatic stellate cells.
RCB3588hPSC-5Human cell line derived from pacreatic cancer. Pancreatic stellate cells.
RCB3589hPSC-14Human cell line derived from pacreatic cancer. Pancreatic stellate cells.
RCB3600SDR-P-1D5Rat prolactin secreting cell line derived from anterior pituitary lacking growth hormone.
RCB3601SDRL-1Rat cell line derived from liver lacking growth hormone.
RCB3602SDRL-2Rat cell line derived from liver lacking growth hormone.
RCB3673RajiHuman cell line derived from Burkitt lymphoma. EBNA (EBV—nuclear antigen) positive. TKG0371(Deposited from Tohoku Univ.).
RCB3675SCC-TCRectal carcinoma. Culture cell line of SCC (TKG 0340) . TKG0646 (Deposited from Tohoku Univ.).
RCB36765637Human cell line derived from bladder carcinoma. TKG0605 (Deposited from Tohoku Univ.).
RCB3677A549Human cell line derived from lung cancer. Epithelial-like cells. HLA-A 2603/3001. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0184(Deposited from Tohoku Univ.).
RCB3678BeWoHuman cell line derived from choriocarcinoma. TKG0567 (Deposited from Tohoku Univ.).
RCB3680HeLaHuman cell line derived from cervical cancer. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0331 (Deposited from Tohoku Univ.).
RCB3681HeLa.P3(S)Subline of HeLa cell line. Serum-free culture is possible. TKG0465 (Deposited from Tohoku Univ.).
RCB3682HeLa S3Human cell line derived from cervical cancer. TKG0444 (Deposited from Tohoku Univ.).
RCB3683HL-60Human cell line derived from promyelocytic leukemia cells. TKG0345 (Deposited from Tohoku Univ.).
RCB3685HMV-IIHuman cell line derived from melanotic melanoma (highly melanotic). TKG0318 (Deposited from Tohoku Univ.).
RCB3686THP-1Human cell line derived from monocytic leukemia. TKG0267 (Deposited from Tohoku Univ.).
RCB3687MKN-7Human cell line derived from stomach cancer (gastric cancer; highly differentiated tubular adenocarcinoma). TKG0228 (Deposited from Tohoku Univ.).
RCB3688Saos-2Human cell line derived from osteogenic sarcoma cells. TKG0469 (Deposited from Tohoku Univ.).
RCB3706Atg7 +/+ MEFsMouse embryonic fibroblasts derived from wild type mouse (C57BL/6).
RCB3707Atg7 -/- MEFsMouse embryonic fibroblasts derived from Atg-deficient mouse (C57BL/6).
RCB3708Atg3 +/+ MEFsMouse embryonic fibroblast cell line derived from wild type C57BL/6 strain.
RCB3709Atg3 -/- MEFsMouse embryonic fibroblast cell line derived from Atg3-deficient C57BL/6 strain.
RCB3710CRP2(A1311A)Currently not ready. Hybridoma against CRP2 (full length) antigen.
RCB3711CDX2(A3701A)Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3712CDX2(A3707A)Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3713CDX2(A371)Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3714CDX2(A3719A)Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3715CDX2(A3722A)Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3716NNMT(A2402A)Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3717NNMT(A2418A)Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3718NNMT(A2433A)Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3719NNMT(A2434A)Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3720NNMT(A2438A)Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3721NNMT(A2440A)Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3722Olig1(A5501A)Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3723Olig1(A5507A)Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3724Olig1(A5508A)Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3725Olig1(A551)Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3726Olig1(A5518A)Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3727Olig2(A5618A)Currently not ready. Hybridoma against Olig2 (full length) antigen.
RCB3728Olig2(A5628A)Currently not ready. Hybridoma against Olig2 (full length) antigen.
RCB3729Olig2(A5629A)Currently not ready. Hybridoma against Olig2 (full length) antigen.
RCB3730Olig2(A5643A)Currently not ready. Hybridoma against Olig2 (full length) antigen.
RCB3731SFRP4(A7113A)Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3732SFRP4(A7116-2A)Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3733SFRP4(A7118A)Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3734SFRP4(A7123A)Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3735SFRP4(A7127-74A)Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3736EPST11(H9209)Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3737EPST11(H9214)Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3738EPST11(H9219)Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3739EPST11(H9220)Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3740EPST11(H9228)Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3741C20-ORF102(H9613)Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3742C20-ORF102(H9615)Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3743C20-ORF102(H9616)Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3744C20-ORF102(H9625)Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3745C20-ORF102(H9627)Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3746C20-ORF102(H9638)Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3747C20-ORF102(H9645)Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3748SP-D5(N2901)Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3749SP-D5(N2906)Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3750SP-D5(N2922)Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3751SP-D5(N2927)Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3752SP-D5(N2931)Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3753SP-D5(N2933)Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3754SP-D5(N2935)Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3755SP-D5(N2942)Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3756PTCH1-2(N7333)Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
RCB3757PTCH1-2(N7346)Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
RCB3758PTCH1-2(N7357)Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
RCB3759PLCη2C(N8320)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3760PLCη2C(N8328)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3761PLCη2C(N8339)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3762PLCη2C(N8346)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3763PLCη2C(N8351)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3764PLCη2C(N8353)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3765PLCη2C(N8357)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3766PLCη2C(N8360)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3767PLCη2C(N8361)Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3768Prdm14-2(N8028)Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
RCB3769Prdm14-2(N8048)Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
RCB3770Prdm14-2(N8070)Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
RCB3771Prdm1-2(N6902)Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3772Prdm1-2(N6915)Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3773Prdm1-2(N6916)Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3774Prdm1-2(N6917)Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3775Prdm1-2(N6927)Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3776HZF2(Y3701)Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
RCB3777HZF2(Y3713)Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
RCB3778HZF2(Y3716)Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
RCB3779HZF3(Y3901)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3780HZF3(Y3916)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3781HZF3(Y3919)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3782HZF3(Y3921)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3783HZF3(Y3923)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3784HZF3(Y3924)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3785HZF3(Y3928)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3786HZF3(Y3932)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3787HZF3(Y3942)Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3788HZF4(Y4006)Currently not ready. Hybridoma against HZF4 : Hematopoietic zinc finger (294-365(72aa)+1amino acid [Ser]) antigen.
RCB3789HZF4(Y4019)Currently not ready. Hybridoma against HZF4 : Hematopoietic zinc finger (294-365(72aa)+1amino acid [Ser]) antigen.
RCB3790tead2(Y3312)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3791tead2(Y3321)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3792tead2(Y3324)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3793tead2(Y3325)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3794tead2(Y3329)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3795tead2(Y3331)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3796tead2(Y3336)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3797tead2(Y3339)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3798tead2(Y3342)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3799tead2(Y3343)Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3800SOCS1-1(Y9208)Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
RCB3801SOCS1-1(Y9213)Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
RCB3802SOCS1-1(Y9215)Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
RCB3803Prdm14-1(N8902)Currently not ready. Hybridoma against Prdm14-1 : PR domain containing14 (1-100(100aa)) antigen.
RCB3804CDK-11(Z0410)Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3805CDK-11(Z0418)Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3806CDK-11(Z0425)Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3807CDK-11(Z0430)Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3808CDK-11(Z0432)Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3809CDK-11(Z0441)Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3810Neurotonin3(Z0835)Currently not ready. Hybridoma against Neurotonin3 : Neurotonin (409-507(99aa)) antigen.
RCB3811Neurotonin4(Z0901-265)Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
RCB3812Neurotonin4(Z0937)Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
RCB3813Neurotonin4(Z0953)Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
RCB3814Neurotonin4(Z0956(222))Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
RCB3815AKAP15(Y0319)Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3816AKAP15(Y0329)Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3817AKAP15(Y0332)Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3818AKAP15(Y0335)Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3819AKAP15(Y0348)Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3820mGli2-2(N9106)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3821mGli2-2(N9109)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3822mGli2-2(N9110)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3823mGli2-2(N9113)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3824mGli2-2(N9119)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3825mGli2-2(N9122)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3826mGli2-2(N9124)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3827mGli2-2(N9133)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3828mGli2-2(N9143)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3829mGli2-2(N9144)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3830mGli2-2(N9145)Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3831SMO-2(B7115B)Currently not ready. Hybridoma against SMO-2 : SMO (470-519 (50aa)) antigen.
RCB3832Wnt4(N0716)Currently not ready. Hybridoma against Wnt4 : Wnt4 (37-77 (41aa)) antigen.
RCB3833Gli1(N5510)Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
RCB3834Gli1(N5516-191)Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
RCB3835Gli1(N5537)Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
RCB3836SMO-1(N5813)Currently not ready. Hybridoma against SMO-1 : SMO (90-172 (83aa)) antigen.
RCB3837Gli3(N6202)Currently not ready. Hybridoma against gp64 fusion Gli3 : GLI family zinc finger 3 (2-60 (59aa)) antigen expressed by baculovirus.
RCB3838Calp7-1(Y0717)Currently not ready. Hybridoma against Calp7-1 : Calpain7 (78-157(80aa)) antigen.
RCB3839Calp7-1(Y0737)Currently not ready. Hybridoma against Calp7-1 : Calpain7 (78-157(80aa)) antigen.
RCB3840PEG10-1(H1805)Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3841PEG10-1(H1807)Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3842PEG10-1(H1812)Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3843PEG10-1(H1827)Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3844PEG10-1(H1829)Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3845PEG10-1(H1831)Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3846TFF1deltaN(H6110)Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3847TFF1deltaN(H6111)Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3848TFF1deltaN(H6112)Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3849TFF1deltaN(H6123)Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3850TFF1deltaN(H6134)Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3851STIP1(H3401)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3852STIP1(H3408)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3853STIP1(H3420)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3854STIP1(H3425)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3855STIP1(H3430)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3856STIP1(H3444)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3857STIP1(H3445)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3858STIP1(H3454)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3859STIP1(H3455)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3860STIP1(H3456)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3861STIP1(H1726)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3862STIP1(H1731)Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3863Rab32(H3502)Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3864Rab32(H3506)Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3865Rab32(H3512)Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3866Rab32(H3513)Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3867Rab32(H3516)Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3868Rab32(H3519)Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3869Rab32(H3521)Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3870GBR7(H4720)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3871GBR7(H4722)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3872GBR7(H4733)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3873GBR7(H4739)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3874GBR7(H4747)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3875GBR7(H4749)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3876GBR7(H4750)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3877GBR7(H4751)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3878GBR7(H4752)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3879GBR7(H4755)Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3880FLJ20442(H5409)Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3881FLJ20442(H5413)Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3882FLJ20442(H5422)Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3883FLJ20442(H5425)Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3884FLJ20442(H5429)Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3885FLJ20442(H5432)Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3886FLJ20442(H5433)Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3887Galectin4(H6004)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3888Galectin4(H6005)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3889Galectin4(H6006)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3890Galectin4(H6007)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3891Galectin4(H6009)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3892Galectin4(H6013)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3893Galectin4(H6015)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3894Galectin4(H6024)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3895Galectin4(H6026)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3896Galectin4(H6034)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3897Galectin4(H6038)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3898Galectin4(H6043)Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3899PAEP(H7001)Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3900PAEP(H7005)Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3901PAEP(H7006)Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3902PAEP(H7011)Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3903PAEP(H701)Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3904PAEP(H7020A)Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3905PAEP(H7026)Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3906PAEP(H7033)Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3907PGC-1(H5953)Currently not ready. Hybridoma against PGC-1 (2-81(80aa)) antigen.
RCB3908STK15(H5701)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3909STK15(H5706)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3910STK15(H5716)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3911STK15(H5723)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3912STK15(H5725)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3913STK15(H5728)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3914STK15(H5737)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3915STK15(H5743)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3916STK15(H5754)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3917STK15(H5755)Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3918*MT(H8602)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3919*MT(H8607)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3920*MT(H8619)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3921*MT(H8624)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3922*MT(H8629)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3923*MT(H8637)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3924*MT(H8638)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3925*MT(H8644)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3926*MT(H8650)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3927*MT(H8655)Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3928DUSP9(H8901)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3929DUSP9(H8902)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3930DUSP9(H8905)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3931DUSP9(H8913)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3932DUSP9(H8914)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3933DUSP9(H8915)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3934DUSP9(H8921)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3935DUSP9(H8922)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3936DUSP9(H8925)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3937DUSP9(H8942)Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3938TIF2(H8403)Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3939TIF2(H8407)Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3940TIF2(H8411)Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3941TIF2(H8414)Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3942TIF2(H8424)Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3943TIF2(H8427)Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3944SKIP(H8514)Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3945SKIP(H8515)Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3946SKIP(H8529)Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3947SKIP(H8530)Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3948SKIP(H8524)Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3949SKIP(H8531)Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3950TRIP13(H9319)Currently not ready. Hybridoma against TRIP13 (2-99 (98aa)) antigen.
RCB3951TRIP13(H9341)Currently not ready. Hybridoma against TRIP13 (2-99 (98aa)) antigen.
RCB3952RCN2(H9757)Currently not ready. Hybridoma against RCN2 (2-99 (98aa)) antigen.
RCB3953RBP2(H9807)Currently not ready. Hybridoma against RBP2 (2-99 (98aa)) antigen.
RCB3954PGC1b-2(N5702)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3955PGC1b-2(N5704)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3956PGC1b-2(N5708)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3957PGC1b-2(N5715)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3958PGC1b-2(N5719)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3959PGC1b-2(N5720)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3960PGC1b-2(N5722)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3961PGC1b-2(N5723)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3962PGC1b-2(N5739)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3963gp64(B8109B)Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3964gp64(B8121A)Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3965gp64(B8137A)Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3966gp64(B8140A)Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3967gp64(B8147A)Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3968mMTMR6(N7705)Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3969mMTMR6(N7706)Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3970mMTMR6(N7712)Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3971mMTMR6(N7715)Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3972mMTMR6(N7725)Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3973mMTMR6(N7739)Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3974SAV-1-N1(Z2011)Currently not ready. Hybridoma against SAV-1-N1 : Salvador homolog 1 (100-149(50aa)) antigen.
RCB3975SAV-1-N1(Z2020)Currently not ready. Hybridoma against SAV-1-N1 : Salvador homolog 1 (100-149(50aa)) antigen.
RCB3976hPPARα-1(Y1820)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3977hFRS2β1(Y7607)Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB3978hPPARα-1(Y1846)Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3979hRev-erbα-1(Y2313)Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3980hRev-erbα-1(Y2319)Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3981hRev-erbα-1(Y2325)Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3982hRev-erbα-1(Y2336)Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3983hRev-erbα-1(Y2339)Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3984hRev-erbα-1(Y2340)Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3985hRev-erbα-1(Y2347)Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3986DKK1(H2907)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3987DKK1(H2910)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3988DKK1(H2913)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3989DKK1(H2914)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3990DKK1(H2922)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3991DKK1(H2927)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3992DKK1(H2928)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3993DKK1(H2933)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3994DKK1(H2936)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3995DKK1(H2940)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3996DKK1(H2945)Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3997hNDR2C(Z1419)Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
RCB3998hNDR2C(Z1440)Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
RCB3999hNDR2C(Y5118)Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
RCB4000NFIA1(Y2230)Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
RCB4001NFIA1(Y2236)Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
RCB4002NFIA1(Y2238)Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
RCB4003NFIA1(Y2240)Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
RCB4004NFIB3(Y2823)Currently not ready. Hybridoma against NFIB3 : Nuclear factor I-B3 (347-414(68aa)) antigen.
RCB4005NFIB3(Y2833)Currently not ready. Hybridoma against NFIB3 : Nuclear factor I-B3 (347-414(68aa)) antigen.
RCB4006NFIX1(Y4402)Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
RCB4007NFIX1(Y4406)Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
RCB4008NFIX1(Y4418)Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
RCB4009NFIX1(Y4424)Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
RCB4010hNRF2-3(Y4902)Currently not ready. Hybridoma against NFIX1 : hNRF2-3 : Nuclear factor erythroid2-related factor 2 (331-390(60aa)) antigen.
RCB4011Bach1-H1(N9502)Currently not ready. Hybridoma against NFIX1 : Bach1-H1 : BTB and CNC homology 1 (317-390(74aa)) antigen.
RCB4012Bach1-H1(N9516)Currently not ready. Hybridoma against NFIX1 : Bach1-H1 : BTB and CNC homology 1 (317-390(74aa)) antigen.
RCB4013Bach1-H2(Y0208)Currently not ready. Hybridoma against NFIX1 : Bach1-H2 : BTB and CNC homology 1 (637-725(89aa)) antigen.
RCB4014Bach1-M1(N9602)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4015Bach1-M1(N9609)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4016Bach1-M1(N9610)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4017Bach1-M1(N9611)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4018Bach1-M1(N9613)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4019Bach1-M1(N9628)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4020Bach1-M1(N9639)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4021Bach1-M1(N9642)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4022Bach1-M1(N9647)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4023Bach1-M1(N9648)Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4024Bach1-M2(Y2103)Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
RCB4025Bach1-M2(Y2117)Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
RCB4026Bach1-M2(Y2133)Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
RCB4027DRPLA-2(N9330)Currently not ready. Hybridoma against DRPLA-2 : Dentato-rubro-pallido-luysian atrophy (101-200(100aa)) antigen.
RCB4028DRPLA-2(N9331)Currently not ready. Hybridoma against DRPLA-2 : Dentato-rubro-pallido-luysian atrophy (101-200(100aa)) antigen.
RCB4029DRPLA-4(Y0435)Currently not ready. Hybridoma against DRPLA-4 : Dentato-rubro-pallido-luysian atrophy (1085-1184(100aa)) antigen.
RCB4030hPTK7-Cyto(Y2040)Currently not ready. Hybridoma against hPTK7-Cyto : Tyrosine-protein kinase-like 7 (725-795(70aa)) antigen.
RCB4031hPTK7-Extra(Y1927)Currently not ready. Hybridoma against hPTK7-Extra : Tyrosine-protein kinase-like 7 (31-130 (100aa)) antigen.
RCB4032hPTK7-Extra(Y1937)Currently not ready. Hybridoma against hPTK7-Extra : Tyrosine-protein kinase-like 7 (31-130 (100aa)) antigen.
RCB4033MEF2A-3(Y0809)Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4034MEF2A-3(Y0833)Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4035MEF2A-3(Y0834)Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4036MEF2A-3(Y0841)Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4037MEF2A-3(Y0847)Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4038MEF2C-2(Y1728)Currently not ready. Hybridoma against MEF2C-2 : Myocyte-specific enhancer factor 2C (161-248(88aa)) antigen.
RCB4039MEF2C-2(Y1740)Currently not ready. Hybridoma against MEF2C-2 : Myocyte-specific enhancer factor 2C (161-248(88aa)) antigen.
RCB4040AFP(B2007C)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4041AFP(B2011D)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4042AFP(B2015C)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4043AFP(B2117C)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4044AFP(B2150D)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4045AFP(B2151D)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4046TFF1(N2306)Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
RCB4047TFF1(N2309)Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
RCB4048TFF1(N2320)Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
RCB4049TFF1(N2325)Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
RCB4050mGCNF-Hinge(N6724)Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
RCB4051mGCNF-Hinge(N6729)Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
RCB4052mGCNF-Hinge(N6737)Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
RCB4053mGCNF-Hinge(N6760)Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
RCB4054mGCNF-N(N6807)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4055mGCNF-N(N6812)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4056mGCNF-N(N6813)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4057mGCNF-N(N6816)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4058mGCNF-N(N6819)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4059mGCNF-N(N6823)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4060mGCNF-N(N6824)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4061mGCNF-N(N6831)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4062mGCNF-N(N6832)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4063mGCNF-N(N6836)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4064mGCNF-N(N6839)Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4065hFOXP3(B8905-6)Currently not ready. Hybridoma against hFOXP3 : Forkhead box P3 (105-190(86aa)) antigen.
RCB4066hFOXP3(B8916B)Currently not ready. Hybridoma against hFOXP3 : Forkhead box P3 (105-190(86aa)) antigen.
RCB4067PPARdelta-1(2-45)(C0309A)Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
RCB4068PPARdelta-1(2-45)(C0309B)Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
RCB4069PPARdelta-1(2-45)(C0309C)Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
RCB4070hRev-erbα-2(Y2408)Currently not ready. Hybridoma against hRev-erbα-2 : Rev-erbα (41-80(40aa)) antigen.
RCB4071hHNF4ɤ-1(Y4602)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4072hHNF4ɤ-1(Y4611)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4073hHNF4ɤ-1(Y4618)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4074hHNF4ɤ-1(Y4621)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4075hHNF4ɤ-1(Y4623)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4076hHNF4ɤ-1(Y4625)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4077hHNF4ɤ-1(Y4626)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4078hHNF4ɤ-1(Y4635)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4079hHNF4ɤ-1(Y4643)Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4080Cys-SN2(N3306)Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4081Cys-SN2(N3312)Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4082Cys-SN2(N3316)Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4083Cys-SN2(N3323)Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4084Cys-SN2(N3331)Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4085Cys-SN2(N3338)Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4086Cys-SN2(N3344)Currently not ready. Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
RCB4087Cys-SN2(N3346)Currently not ready. Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
RCB4088Cys-SN2(N3349)Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4089Cys-SN2(N3372)Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4090TRβ-CT(H9401)Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
RCB4091TRβ-CT(H9420)Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
RCB4092TRβ-CT(H9431)Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
RCB4093TRβ-CT(H9437)Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
RCB4094mGli2(N7206)Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
RCB4095mGli2(N7212)Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
RCB4096mGli2(N7219)Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
RCB4097mGli2(N7237)Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
RCB4098mTES101-RP(N6002)Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4099mTES101-RP(N6022A)Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4100mTES101-RP(N6022B)Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4101mTES101-RP(N6035)Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4102mTES101-RP(N6038)Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4103TADA3(B0331A)Currently not ready. Hybridoma against TADA3 (3-49 (61-160 (100aa)) antigen.
RCB4104WBP2(N2617)Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
RCB4105WBP2(N2640)Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
RCB4106WBP2(N2645)Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
RCB4107AI-gp(Y3111)Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4108AI-gp(Y3123)Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4109AI-gp(Y3124)Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4110AI-gp(Y3127)Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4111AI-gp(Y3147)Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4112AFP(B592)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4113AFP(B5937F)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4114AFP(B5939D)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4115AFP(B5944F)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4116AFP(B5955D)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4117AFP(B5963D)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4118AFP(B5980D)Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4119CCR5 SP3(Y4108)Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
RCB4120CCR5 SP3(Y4125)Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
RCB4121CCR5 SP3(Y4126)Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
RCB4122mNCoR-1(Y8110)Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
RCB4123mNCoR-1(Y8111)Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
RCB4124mNCoR-1(Y8129)Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
RCB4125mNCoR-1(Y8131(A))Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
RCB4126mSRC-1(Y8207)Currently not ready. Hybridoma against mSRC-1 (626-668(43aa)) antigen.
RCB4127mSRC-1(Y8243)Currently not ready. Hybridoma against mSRC-1 (626-668(43aa)) antigen.
RCB4128HSMRT(Y9017)Currently not ready. Hybridoma against HSMRT (1922-2043(122aa)) antigen.
RCB4129HSMRT(Y9033)Currently not ready. Hybridoma against HSMRT (1922-2043(122aa)) antigen.
RCB4130hRIP140(Y9140)Currently not ready. Hybridoma against hRIP140 (733-847(11a)) antigen.
RCB4131hTIF2(Y8917)Currently not ready. Hybridoma against hTIF2 (733-847(753-804(52aa)) antigen.
RCB4132hTIF2(Y8918)Currently not ready. Hybridoma against hTIF2 (733-847(753-804(52aa)) antigen.
RCB4133BAP37(Z1131B)Currently not ready. Hybridoma against BAP37 : B-cell receptor-associated protein 37 (210-249(40aa)) antigen.
RCB4134SOX21 PepT3(Z3001)Currently not ready. Hybridoma against SOX21 PepT3 : SRY (sex determining region Y)-box 21 (129-176(48aa)) antigen.
RCB4135Epc1AG(Z3703)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4136Epc1AG(Z3705)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4137Epc1AG(Z3710)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4138Epc1AG(Z3714)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4139Epc1AG(Z3715)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4140Epc1AG(Z3716)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4141Epc1AG(Z3725)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4142Epc1AG(Z3728)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4143Epc1AG(Z3733)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4144Epc1AG(Z3741)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4145Epc1AG(Z3742)Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4146Epc2AG(Z3901)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4147Epc2AG(Z3906)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4148Epc2AG(Z3908)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4149Epc2AG(Z3911)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4150Epc2AG(Z3921)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4151Epc2AG(Z3922)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4152Epc2AG(Z3925)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4153Epc2AG(Z3931)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4154Epc2AG(Z3934)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4155Epc2AG(Z3940)Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4156STK3(Z2801)Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4157STK3(Z2804)Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4158STK3(Z2814)Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4159STK3(Z2816)Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4160STK3(Z2822)Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4161STK3(Z2828)Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4162STK3(Z2829)Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4163mDAI-3S(Z4401)Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4164mDAI-3S(Z4410)Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4165mDAI-3S(Z4415)Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4166mDAI-3S(Z4420)Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4167mDAI-3S(Z4424)Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4168mDAI-3S(Z4429)Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4169mDAI-3S(Z4402)Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4170mDAI-3S(Z4418)Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4171JHDM2A-3C(Z5507)Currently not ready. Hybridoma against JHDM2A-3C : Jumonji domain containing gene family of histone demethylase 2A (1151-1224(74aa)) antigen.
RCB4172JHDM2A-4C(Z6316)Currently not ready. Hybridoma against JHDM2A-4C : Jumonji domain containing gene family of histone demethylase 2A (1089-1138(50aa)) antigen.
RCB4173HIF1(Z6413)Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(4a)) antigen.
RCB4174HIF1(Z6414)Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(4a)) antigen.
RCB4175HIF1(Z6417)Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(4a)) antigen.
RCB4176HIF1(Z6437)Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(4a)) antigen.
RCB4177HIF2(Z6502)Currently not ready. Hybridoma against HIF2 : Hypoxia-inducible transcription factor 2 (603-652(50aa)) antigen.
RCB4178HIF2(Z6526)Currently not ready. Hybridoma against HIF2 : Hypoxia-inducible transcription factor 2 (603-652(50aa)) antigen.
RCB4179p65-12(Z6635)Currently not ready. Hybridoma against p65-12 : p65 (116-168(53aa)) antigen.
RCB4180Mrf2-2(Z7411)Currently not ready. Hybridoma against Mrf2-2 : Modulator recognition factor 2 (1140-1189(50aa)) antigen.
RCB4181Mrf2-2(Z7437)Currently not ready. Hybridoma against Mrf2-2 : Modulator recognition factor 2 (1140-1189(50aa)) antigen.
RCB4182THRAP3(Z6803)Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
RCB4183THRAP3(Z6824)Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
RCB4184THRAP3(Z6832)Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
RCB4185THRAP3(Z6840)Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
RCB4186KLF4(Z6902)Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4187KLF4(Z6913)Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4188KLF4(Z6919)Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4189KLF4(Z6928)Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4190KLF4(Z6929)Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4191KLF4(Z6943)Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4192KLF4(Z6944)Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4193CCR4aN(Y6206)CCR4aN : CCR4-NOT transcription complex, subunit 6 (141-190(50aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4194CCR4bC(Y5601)Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(5a)) antigen.
RCB4195CCR4bC(Y5606)Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(5a)) antigen.
RCB4196CCR4bC(Y5657)Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(5a)) antigen.
RCB4197SETD3(Y2501)Currently not ready. Hybridoma against SETD3 : SET domain containing 3 (2-139(138aa)) antigen.
RCB4198SETD3(Y2537)Currently not ready. Hybridoma against SETD3 : SET domain containing 3 (2-139(138aa)) antigen.
RCB4199mSETDB2-1(Y7221)Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4200mSETDB2-1(Y7227)Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4201mSETDB2-1(Y7228)Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4202mSETDB2-1(Y7232)Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4203mSETDB2-1(Y7241)Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4204mSETDB2-1(Y7246)Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4205mSETDB2-1(Y7247)Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4206Prdm6-2(Y7126)Currently not ready. Hybridoma against Prdm6-2 : PR domain containing 6 (294-392(99aa)) antigen.
RCB4207Prdm16-1(Z0311)Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4208Prdm16-1(Z0315)Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4209Prdm16-1(Z0324)Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4210Prdm16-1(Z0327)Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4211Prdm16-1(Z0346)Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4212Prdm16-2(Z1301)Currently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
RCB4213Prdm16-2(Z1312)Currently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
RCB4214Prdm16-2(Z1322)Currently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
RCB4215Prdm2-2(Z0601)Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4216Prdm2-2(Z0605)Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4217Prdm2-2(Z0626)Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4218Prdm2-2(Z0631)Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4219Prdm2-2(Z0654)Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4220Prdm4-1(Y8328)Currently not ready. Hybridoma against Prdm4-1 : PR domain containing 4 (161-260(100aa)) antigen.
RCB4221Prdm4-1(Y8341)Currently not ready. Hybridoma against Prdm4-1 : PR domain containing 4 (161-260(100aa)) antigen.
RCB4222COUP TFII-2(Z0504)Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
RCB4223COUP TFII-2(Z0523)Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
RCB4224COUP TFII-2(Z0533)Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
RCB4225methylated budded baculovirus(C4914-2)Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4226methylated budded baculovirus(C4930-101)Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4227methylated budded baculovirus(C5006-9)Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4228methylated budded baculovirus(C5009-33)Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4229methylated budded baculovirus(C5032-60)Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4230methylated budded baculovirus(C5123-70)Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4231ATIP-CT(N4204)Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
RCB4232ATIP-CT(N4207)Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
RCB4233ATIP-CT(N4235)Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
RCB4234ROBO1 Ag1(Y4314)Currently not ready. Hybridoma against ROBO1 Ag1 : Roundabout 1 (946-1034(89aa)) antigen.
RCB4235ROBO1 Ag2(Y7002)Currently not ready. Hybridoma against ROBO1 Ag2 : Roundabout 1 (1062-1148(87aa)) antigen.
RCB4236ROBO1 Ag6(Y8411)Currently not ready. Hybridoma against ROBO1 Ag6 : Roundabout 1 (1458-1555(98aa)) antigen.
RCB4237APE-C(Y1202)Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4238APE-C(Y1209)Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4239APE-C(Y1215)Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4240APE-C(Y1220)Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4241APE-C(Y1221)Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4242APE-C(Y1244)Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4243APE-N1(N9406)Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4244APE-N1(N9407)Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4245APE-N1(N9426)Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4246APE-N1(N9436A)Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4247APE-N1(N9436B)Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4248APE-N1(N9442)Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4249APE-N3(Y0013)Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
RCB4250APE-N3(Y0026)Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
RCB4251APE-N3(Y0028)Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
RCB4252APE-N3(Y0038)Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
RCB4253hTobC(Y5432)Currently not ready. Hybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
RCB4254hTobC(Y5443)hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4255hTobC(Y5444)hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4256hTobC(Y5452)hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4257hTobM(Y5807)Currently not ready. Hybridoma against hTobM : Transducer of ERBB2, 1 (136-236(101aa)) antigen.
RCB4258hTobM(Y5815)Currently not ready. Hybridoma against hTobM : Transducer of ERBB2, 1 (136-236(101aa)) antigen.
RCB4259p115-C(Y0902)Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4260p115-C(Y0912)Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4261p115-C(Y0915)Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4262p115-C(Y0920)Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4263p115-C(Y0921)Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4264p115-C(Y0924)Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4265p115-C(Y0931)Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4266p115-C(Y0945)Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4267LARG-C term(Y9601)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4268LARG-C term(Y9614)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4269LARG-C term(Y9618)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4270LARG-C term(Y9619)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4271LARG-C term(Y9625)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4272LARG-C term(Y9626)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4273LARG-C term(Y9627)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4274LARG-C term(Y9637)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4276ATIP-CT(C1708-1)Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426 (100aa)) antigen.
RCB4277ATIP-CT(C1717-5)Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426 (100aa)) antigen.
RCB4278NM6(Y0620)Currently not ready. Hybridoma against NM6 : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4279NM6s(Y67002)Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4280NM6s(Y67003)Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4281NM6s(Y67057)Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4282NM6s(Y67081)Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4283NM6s(Y67109)Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4284CM1s(Z1001)Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4285CM1s(Z1002)Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4286CM1s(Z1014)Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4287CM1s(Z1016)Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4288CM1s(Z1057)Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4289CM6(Y9506)Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
RCB4290CM6(Y9512)Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
RCB4291CM6(Y9515)Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
RCB4292CM6(Y9517)Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
RCB4293hVir-2(Y1503)Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
RCB4294hVir-2(Y1513)Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
RCB4295hVir-2(Y1523)Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
RCB4296hVir-3(Y1613)Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
RCB4297hVir-3(Y1625(4C3))Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
RCB4298hVir-3(Y1639)Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
RCB4299WTAP(Y6809)Currently not ready. Hybridoma against WTAP : Wilms tumor 1 associated protein (6-76(71aa)) antigen.
RCB4300WTAP(Y6828)Currently not ready. Hybridoma against WTAP : Wilms tumor 1 associated protein (6-76(71aa)) antigen.
RCB4301hFRS2β1(Y7610)Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4302hFRS2β1(Y7612)Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4303hFRS2β1(Y7624)Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4304hFRS2β1(Y7632)Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4305hFRS2β1(Y7641)Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4306hFRS2β1(Y7642)Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4307hFRS2β1(Y7643)Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4308mNFATC-N(Y7402)Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
RCB4309mNFATC-N(Y7405)Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
RCB4310mNFATC-N(Y7428)Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
RCB4311mNFATC-N(Y7445)Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
RCB4312hEgr1(N8605)Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4313hEgr1(N8611)Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4314hEgr1(N8614)Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4315hEgr1(N8616)Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4316hEgr1(N8637)Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4317hEgr1(N8640)Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4318hEgr3(N8701)Currently not ready. Hybridoma against hEgr3 : Early growth response 3 (27-82(56aa)) antigen.
RCB4319hEgr3(N8730)Currently not ready. Hybridoma against hEgr3 : Early growth response 3 (27-82(56aa)) antigen.
RCB4320Prdm8-2(N8501)Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4321Prdm8-2(N8506)Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4322Prdm8-2(N8508)Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4323Prdm8-2(N8513)Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4324Prdm8-2(N8520)Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4325Prdm8-2(N8526)Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4326Prdm8-2(N8533)Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4327Aggrecan-1(Y3416)Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4328Aggrecan-1(Y3428)Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4329Aggrecan-1(Y3431)Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4330Aggrecan-1(Y3441)Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4331Aggrecan-1(Y3446)Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4332PTX3N46(Z3805(421))Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4333PTX3N46(Z3818-1-19)Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4334PTX3N46(Z3821(100))Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4335PTX3N46(Z3825(125))Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4336PTX3N46(Z3829-156)Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4337PTX3N46(Z3835-467)Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4338PTX3N46(Z3839-590)Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4339CBLL1-2(Y6018)Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4340CBLL1-2(Y6026)Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4341CBLL1-2(Y6037)Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4342CBLL1-2(Y6047)Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4343CBLL1-2(Y6048)Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4344CBLL1-1(Y6610)Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
RCB4345CBLL1-1(Y6621)Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
RCB4346CBLL1-1(Y6641)Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
RCB4347PDZ-CS(Y7501)Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4348PDZ-CS(Y7504)Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4349PDZ-CS(Y7505)Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4350PDZ-CS(Y7534)Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4351PDZ-CS(Y7537)Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4352Ets-1 Mid(Y8012)Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(8a)) antigen.
RCB4353Ets-1 Mid(Y8020)Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(8a)) antigen.
RCB4354Ets-1 Mid(Y8029)Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(8a)) antigen.
RCB4355prdm 5(C2518A)Currently not ready. Hybridoma against gp64 fusion prdm 5 : PR domain containing 5 (10-110(101aa)) antigen expressed by baculovirus.
RCB4356RGS3T(C6501-4)Currently not ready. Hybridoma against RGS3T : regular of G protein signaling 3 (full length) antigen.
RCB4357Gq(C6604-5)Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4358Gq(C6611A-11-A2)Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4359Gq(C6611B-35-18)Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4360Gq(C6618-81)Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4361Gq(C6623-18)Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4362Gα13(C9101-F5-1)Currently not ready. Hybridoma against Gα13 : GNA12 (full length) antigen.
RCB4363Gα13(C9201-B5-4)Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
RCB4364Gα13(C9202-F9-1)Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
RCB4365Gα13(C9204-D4-1)Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
RCB4366Gα13(C9205-F6-4)Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
RCB4367Gα12(D0901-A1-E11)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4368Gα12(D0902-B12-G11)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4369Gα12(D0904-A6-H2)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4370Gα12(D0906-B10-D6)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4371Gα12(D0907-E2-E8)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4372Gα12(D0908-G5-A6)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4373Gα12(D0910-G5-D10)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4374Gα12(D0911-E6-G1)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4375Gα12(D0912-B5-C9)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4376Gα12(D0914-D5-D4)Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4377NFATC-3(Z2705)Currently not ready. Hybridoma against NFATC-3 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (35-107(73aa)) antigen.
RCB4378mOSR-2(Z2914)Currently not ready. Hybridoma against mOSR-2 : Odd-skipped related 2 (59-157(99aa) antigen.
RCB4379ATOX1(Z3101)Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4380ATOX1(Z3112)Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4381ATOX1(Z3138)Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4382ATOX1(Z3140)Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4383ATOX1(Z3144)Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4384MAN-1(Z4201)Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4385MAN-1(Z4202)Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4386MAN-1(Z4205)Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4387MAN-1(Z4209)Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4388MAN-1(Z4221)Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4389MAN-1(Z4222)Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4390MAN-1(Z4223)Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4391MAN-1(Z4237)Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4392SETDB-1(Z4601)Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
RCB4393SETDB-1(Z4606)Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
RCB4394SETDB-1(Z4613)Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
RCB4395SETDB-1(Z4630)Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
RCB4396mp250GAP(Z4906)Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4397mp250GAP(Z4932)Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4398mp250GAP(Z4937)Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4399mp250GAP(Z4942)Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4400mp250GAP(Z4946)Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4401mp250GAP(Z4947)Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4402SETD5-1(Z5235-36)Currently not ready. Hybridoma against SETD5-1 : SET domain containing 5 (43-93(51aa)) antigen.
RCB4403SETD5-1(Z5235-42)Currently not ready. Hybridoma against SETD5-1 : SET domain containing 5 (43-93(51aa)) antigen.
RCB4404NFATC1-2(Z5302)Currently not ready. Hybridoma against NFATC1-2 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (134-223(90aa)) antigen.
RCB4405NFATC1-2(Z5321)Currently not ready. Hybridoma against NFATC1-2 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (134-223(90aa)) antigen.
RCB4406GluR1-1(Z6114)Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4407GluR1-1(Z6119)Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4408GluR1-1(Z6123)Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4409GluR1-1(Z6135)Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4410GluR1-1(Z6141)Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4411GluR1-1(Z6143)Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4412SETD5-4(Z5702-3)Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4413SETD5-4(Z5704-209)Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4414SETD5-4(Z5708-71)Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4415SETD5-4(Z5714-114)Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4416SETD5-4(Z5721-234)Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4417PRMT1-N(Z5017)Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
RCB4418PRMT1-N(Z5018)Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
RCB4419PRMT1-N(Z5026)Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
RCB4420NM1S/Tg(Z7332)Currently not ready. Hybridoma against NM1S/Tg : Myotubular myopathy 1 (1-50(50aa)) antigen.
RCB4421NM1S/Tg(Z7342)Currently not ready. Hybridoma against NM1S/Tg : Myotubular myopathy 1 (1-50(50aa)) antigen.
RCB4422CM3(Z7511)Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
RCB4423CM3(Z7528)Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
RCB4424CM3(Z7536)Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
RCB4425NM3(Z8021)Currently not ready. Hybridoma against NM3 : Myotubularin related protein 3 (1-50(50aa)) antigen.
RCB4426CM4/Tg(Z8214)Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
RCB4427CM4/Tg(Z8217)Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
RCB4428CM4/Tg(Z8245B)Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
RCB4429Fbxl 10-N(Z8310)Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4430Fbxl 10-N(Z8312)Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4431Fbxl 10-N(Z8320)Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4432Fbxl 10-N(Z8327)Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4433Fbxl 10-N(Z8345)Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4434LARG-C term(D4004-4E2-6)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4435LARG-C term(D4005-6A6-29)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4436LARG-C term(D4101-2G11-41)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4437LARG-C term(D4106-5G1-67)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4438LARG-C term(D4107-5H2-110)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4439LARG-C term(D4202-2E6-130)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4440LARG-C term(D4204-1A10-163)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4441LARG-C term(D4205-2A9-213)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4442LARG-C term(D4206-2B8-221)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4443LARG-C term(D4207-2D10-262)Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4444Emerin Ab-3(D2702-12)Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4445Emerin Ab-3(D2703-2)Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4446Emerin Ab-3(D2704-5)Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4447Emerin Ab-3(D2705-2)Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4448Emerin Ab-3(D2738-2)Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4451UPS-1Sub-line of CHO-K1 which is defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine (C6-NBD-PS).
RCB4452FL-YBMouse follicular dendritic cell line
RCB4455PC-9Human cell line derived from lung adenocarcinoma cells. Differentiated type. Previous name:PC-14(RCB0446)
RCB4472IN-ICRat cell line derived from kidney.
RCB4474Ba/F3-CL1Mouse pro-B cell line derived from C3H strain. IL-3 dependent. After cloning (RCB0805 Ba/F3).　Information
RCB4476Ba/F3Mouse pro-B cell line derived from C3H strain. IL-3 dependent. Information
RCB4477ACK2Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
RCB4478ACK4Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
RCB4479ACK30Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
RCB4480ACK45Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
RCB4481A7R34Hybridoma cell line producing anti-mouse IL-7 Receptor alpha (CD127) antibody.
RCB4482APA5Hybridoma cell line producing anti-mouse PDGF Receptor alpha (CD140a) antibody.
RCB4483APB5Hybridoma cell line producing anti-mouse PDGF Receptor beta (CD140b) antibody.
RCB4484Avas12Hybridoma cell line producing anti-mouse Flk-1/VEGF-Receptor 2 (CD309) antibody.
RCB4485A2F10Hybridoma cell line producing anti-mouse Flk-2/Flt-3 (CD135) antibody.
RCB4486AFS98Hybridoma cell line producing anti-mouse c-fms (CD115) antibody.
RCB4487ACD1Hybridoma cell line producing anti-mouse CDK4 antibody.
RCB4488AFL4Hybridoma cell line producing anti-mouse VEGF-Receptor 3 antibody.Application consideration
RCB4489MB86Hybridoma cell line producing anti-mouse IgM(b)/Igh6b antibody.
RCB4498NP 2Human cell line derived from anaplastic glioma.
RCB4499Onda 10Human cell line derived from anaplastic glioma.
RCB4500Onda 11Human cell line derived from glioblastoma.
RCB4504NP 3Human cell line derived from anaplastic glioma.
RCB4505NP 5Human cell line derived from anaplastic glioma.
RCB4516STIM2^(-/-)DT40A subline of avian cell line, DT40, lacking STIM2 gene.
RCB4517STIM1^(-/-)STIM2^(-/-)DT40A subline of avian cell line, DT40, lacking both STIM1 and STIM2 genes.
RCB4518Orai1^(-/-)DT40A subline of avian cell line, DT40, lacking Orai1 gene.
RCB4519Orai2^(-/-)DT40A subline of avian cell line, DT40, lacking Orai2 gene.
RCB4548PT-rRat cell line derived from parathyroid gland.
RCB4561MOLT-17Human cell line derived from T cell leukemia (T-ALL). ACC 36 (Deposited from DMSZ.).
RCB4563TSt-4/N-DLL4Original murine mesenchymal cell line was derived from fetal thymus tissue. A line Expressing DLL4 gene.
RCB4566TEC1C8 
RCB4568TEC2-3 
RCB4569TEC3-10 
RCB4592r/mHM-SFME-1 
RCB4593CALM WT MEFCALM non-deficient MEF cells. Tranformed with SV40 large T antigen gene.
RCB4594CALM KO MEFCALM deficient MEF cells. Tranformed with SV40 large T antigen gene.
RCB4623Ba/ERBa/ER was created by stable transfection of murine pro-B Ba/F3 cells with a murine erythropoietin receptor gene. Ba/ER proliferates dependent on erythropoietin or interleukin-3.
RCB4627KUP5An immortalized mouse Kupffer cell line established from C57BL/6 strain. The Kupffer cells were proliferated in the mixed primary culture of C57BL/6 adult mouse liver cells, then infected with a replication-deficient retroviral vector containing the human c-myc oncogene and neomycin resistance gene, isolated and selected with G418 (cloned by a limited dilution).
RCB4635#16-15Hybridoma cell line producing anti-human BEND3 antibody (rat IgM).
RCB4662HCT116 CMV-OsTIR1cf.： Kanemaki’s Auxin Inducible Degron (AID) System
RCB4676HeLa/Fucci(CA)2Important notice regarding nomenclature of Fucci.
RCB4679HepG2-NIASA subline of HepG2 cells that can not only rapidly activate hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity but also induce the formation of bile canaliculus-like structures by utilizing a collagen vitrigel membrane as a culture substratum.
RCB4680MS-5Mouse stromal cell line which supports hematopoietic cells.
RCB4681MS-KMurine cell line derived from sarcoma.
RCB46836330403Rik 
RCB4684celf3 
RCB4685Dgcr14 
RCB4693ChR2-C2C12A subline of the murine C2C12 cell line　(RCB0987) which stably expresses　channelrhodopsin 2-Venus (ChR2-Venus), one of light-gated cation channels derived from a green alga Chlamydomonas reinhardtii, tagged with a fluorescent protein, Venus.
RCB4695GFP-LC3-RFP-LC3ΔG HeLa 
RCB4696GFP-LC3-RFP-LC3ΔG MEF 
RCB4724A2A(C2702-B05-52)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4725A2A(C2704-C07-89)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4726A2A(C2831-104)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4727A2A(C2838-190)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4728A2A(C3007-E6)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4729A2A(C3019-B-203-B3)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4730A2A(C3024-43)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4731A2A(C3025-95)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4732A2A(C3029A-236)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4733A2A(C3044-10)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4734A2A(C3080-145)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4735A2A(C3138G3(A))Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4736A2A(C3160-79)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4737A2A(C3169-214)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4738A2A(C3978B-D4)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4739A2A(C3938B-F6)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4740A2A(C3943B-E3)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4741A2A(C40006-123)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4742A2A(C40010-A6)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4743A2A(C40011-G11)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4744A2A(C40037-A5)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4745A2A(C40040-A12)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4746A2A(C40056-G6)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4747A2A(C40076-173)Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4748M2(C1801-A9-16)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4749M2(C1802-B4-42)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4750M2(C1803-C2-74)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4751M2(C1805-E5-95)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4752M2(C1901-C4-152)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4753M2(C3603-D10-1)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4754M2(C4729-H1-3)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4755M2(C4804-3)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4756M2(C4817-1)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4757M2(C4814-E10-3)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4758M2(C5708-1)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4759M2(C5801-3)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4760M2(C5903-1)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4761M2(D0303-12)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4762M2(D0368-63-A1-16)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4763M2(D0403-13)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4764M2(D0423-15)Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4765Band3(C4201-A1-10)Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
RCB4766Band3(C4203-D3-26)Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
RCB4767Band3(C4204-C3-48)Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
RCB4768Band3(C4206-G7-90)Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
RCB4769Glut5(C45053-H4)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4770Glut5(C45085-F2)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4771Glut5(C45107-102)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4772Glut5(C45019-3)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4773Glut5(C45077-49)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4774Glut5(C45106-78)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4775Glut5(C45021-34)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4776Glut5(C45004-016)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4777Glut5(C45008-054)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4778Glut5(C45037-101)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4779Glut5(C45080-134)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4780Glut5(C45081-146)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4781Glut5(C45119-160)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4782Glut5(C45124-214)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4783Glut5(C45125-237)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4784Glut5(C45032-73)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4785Glut5(C45120-263-A4)Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4786v-ATP ase VoV1(C87076-007)Currently not ready. Hybridoma against v-ATP ase CL : v-ATP ase (CL domain) antigen.
RCB4787v-ATP ase VoV1(C87076-014)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4788v-ATP ase VoV1(C87079-067)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4789v-ATP ase VoV1(C87119-130)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4790v-ATP ase VoV1(C87119-132)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4791v-ATP ase VoV1(C87119-148)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4792v-ATP ase VoV1(C87160-164)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4793v-ATP ase VoV1(C87187-276)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4794v-ATP ase VoV1(C87159B-111)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4795v-ATP ase VoV1(C9017-349)Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4796v-ATP ase CL(E72013-2C2-94)Currently not ready. Hybridoma against v-ATP ase CL : v-ATP ase (CL domain) antigen.
RCB4797HRH1(D2205-A8)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4798HRH1(D2210-C9)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4799HRH1(D2201-D7)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4800HRH1(D2315-H6)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4801HRH1(D2335-A10)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4802HRH1(D2351-H7)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4803HRH1(D2335-F8)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4804HRH1(D2363-H11)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4805HRH1(D2326-G6-F12)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4806HRH1(D2323-H5)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4807HRH1(D2340-67)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4808HRH1(D2401-E6)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4809HRH1(D2503-B5)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4810HRH1(D2510-110)Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4811Glut1(D3638-22)Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4812Glut1(D3643-9)Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4813Glut1(D4425-2)Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4814Glut1(D4416-3)Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4815Glut1(D4417-14)Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4816Glut1(D4402-6)Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4817Glut1(D4418-30)Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4818Glut1(D4404-9)Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4831AT2(D5604-006)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4832AT2(D5614-054)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4833AT2(D5608-040)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4834AT2(D5647-129)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4835AT2(D5655-150)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4836AT2(D5630-095)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4837AT2(D5605-011)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4838AT2(D5640-072)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4839AT2(D5620-032)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4840AT2(D5626-060)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4841AT2(D5711-4A03-B03)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4842AT2(D5713-4C10-290)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4843AT2(D5725-3B08-369)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4844AT2(D5702-1A09-173)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4845AT2(D5705-1E10-208)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4846AT2(D5711-2H02-A01)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4847AT2(D5714A-4D07-334)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4848AT2(D5706-1F03-149)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4849AT2(D5709-1H06-187)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4850AT2(D5711-2H05-229)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4851AT2(D5701-1A07-116)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4852AT2(D5712-4A08-236)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4853AT2(D5707-1G02-158)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4854AT2(D5722-2D12-202)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4855AT2(D5701-1A06-100)Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4856TACR2(D8116-4C1-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4857TACR2(D8103-3F12-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4858TACR2(D8210-5D5-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4859TACR2(D8213-1-3)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4860TACR2(D83007-3)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4861TACR2(D83010-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4862TACR2(D83008-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4863TACR2(D84042-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4864TACR2(D84048-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4865TACR2(D84072-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4866TACR2(D84026-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4867TACR2(D84083-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4868TACR2(D84112-1)Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4869GluR1-2(Z9139)Currently not ready. Hybridoma against GluR1-2 (mouse) : GluA1 AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor (236~286 aa) antigen.
RCB4870AQP4(C9401-A3-29)Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4871AQP4(D12092-1C3-02)Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4872AQP4(D15107-3D7-33)Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4873AQP4(E3634-13)Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4874AQP4(E3641-70)Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4875AQP4(E3635-60-A7)Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4876AQP4(E3726A-122)Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4877AQP4(E3716-94)Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4878AQP4(E3726B-130)Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4879AQP4(E5206-1B10-8)Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4880AQP4(E5209-1C8-22)Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4881AQP4(E5407-1E6-32)Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4882AQP4(E5413-1G11-49)Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4883AQP4(E541-1H6-68)Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4884AQP4(E5415B-1H7-79)Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4885AQP4(E5507-3A1-113)Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4886AQP4(E5505-3D12-129)Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4887AQP4(E5504-2G2-105)Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4888DP2(D5201-1A5-6)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4890DP2(D5302-3A4-82)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4891DP2(D5305-3B3-103)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4892DP2(D5502-135)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4893DP2(D5513-2-B1)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4894DP2(D5516-176)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4895DP2(D5517-208-A2)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4896DP2(D5524-228)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4897DP2(D5531-258)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4898DP2(D5534-265)Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4899NRF3-2(E9403-D3-A5-1)Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4900NRF3-2(E9405-1)Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4901NRF3-2(E9408-1)Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4902NRF3-2(E9413-G1-A3-1)Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4903NRF3-2(E9422-D2-B9-1)Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4907DHHC1(D8013-1C11-6)Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
RCB4908DHHC1(D8018-1D10-26)Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
RCB4909DHHC1(D8018-1D10-35)Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
RCB4910DHHC10(E2601-1C3-2)Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4911DHHC10(E2607-1F6-23)Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4912DHHC10(E2611-1H2-49)Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4913DHHC10(E2614-3B1-69)Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4914DHHC10(E2701-2B3-97)Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4915DHHC10(E2706-2F7-135)Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4936CT27TS culture protocol
RCB4937CT29TS culture protocol
RCB4938CT30TS culture protocol
RCB4940bTS5TS culture protocol
RCB4941bTS11TS culture protocol
RCB4942BHK/T7-9 
RCB5004CHL-YNApplication consideration

 

 

 

 

 

 

 

乐鸿捕鱼苹果官方版下载
地址：上海浦东川沙镇川沙路6619号乐鸿捕鱼苹果官方版下载
邮箱：xs1@78bio.com
传真：021-50724961
快速链接
关注我们
欢迎您关注我们的微信公众号了解更多信息：
欢迎您关注我们的微信公众号
了解更多信息
版权所有 © 2025 乐鸿捕鱼苹果官方版下载 (www.zhaijibian.com) All Rights Reserved      备案号：沪ICP备11048721号-2      管理登陆      技术支持：化工仪器网      sitemap.xml
Baidu
map